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Dynein mediates unidirectional nuclear movement toward the microtubule organizing center. Erythroid
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previously unappreciated mode of regulation for dynein, which is critical for many cellular processes.
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ABSTRACT 
 
THE ROLE OF TRIM58 IN ERYTHROPOIESIS 
Christopher S Thom 
Mitchell J Weiss, MD, PhD 
 
Red blood cells (erythrocytes) deliver oxygen to all tissues of the body. Defects in 
red blood cell production (erythropoiesis) can cause disease. Mammalian erythropoiesis 
culminates in enucleation, an incompletely understood process that entails the physical 
separation of the nucleus and cytoplasm. The work in this thesis investigated the role of 
a previously uncharacterized protein named Trim58 in erythropoiesis.  
Human genetic studies suggested that TRIM58 played an important role in 
erythroid development. In humans and mice, Trim58 expression was found to be 
restricted to red blood cell precursors during late stage maturation. In fact, murine 
Trim58 was upregulated just prior to enucleation. Using short hairpin RNAs, Trim58 
expression was inhibited in cultured murine erythroblasts. Through a variety of analyses, 
it was demonstrated that Trim58 is dispensable for early erythroid maturation. However, 
Trim58 knockdown impaired movement of the nucleus, thereby inhibiting enucleation.  
Trim58 is a member of the tripartite motif-containing family of proteins, many of 
which function as E3 ubiquitin ligases that can facilitate protein degradation. Protein 
interaction studies demonstrated that Trim58 bound directly to the molecular motor 
protein complex dynein. Consistent with its putative role as an E3 ubiquitin ligase, 
ectopic Trim58 expression in HeLa cells caused dynein degradation in a proteasome-
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dependent fashion. Furthermore, dynein loss and efficient enucleation were coincident 
and dependent upon Trim58 induction during erythroid culture maturation.  
Dynein mediates unidirectional nuclear movement toward the microtubule 
organizing center. Erythroid enucleation requires nuclear movement in the opposite 
direction. Hence, Trim58-mediated dynein degradation may be responsible for nuclear 
movement during enucleation. Our findings identify Trim58 as the first erythroid-specific 
protein that regulates this process. More broadly, regulated proteolysis represents a 
previously unappreciated mode of regulation for dynein, which is critical for many cellular 
processes. 
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CHAPTER 1: INTRODUCTION  
 
Red blood cell development is a complex process, with some aspects that are 
rare or unique within the realm of cell biology. For example, late in their development, 
mammalian erythroblasts expel their nucleus. The genes and processes that facilitate 
enucleation are not well understood, and I investigated this interesting process during 
the course of my graduate work. Genetic tools led us to identify Trim58 as a relatively 
erythroid-specific gene that we functionally linked with enucleation.  
This introduction aims to concisely describe prior work that informed our studies. 
A basic appreciation of several biological processes is necessary to understand our 
hypotheses and our investigation. These topics include red blood cell development, and 
in particular enucleation; how microtubule molecular motors, like dynein, facilitate 
nuclear movement; and how proteins are degraded via the ubiquitin-proteasome system. 
Red blood cell development, molecular motor activities, and protein degradation are all 
complex and intensively studied areas of biology. For general overviews of these 
subjects, the reader is referred to excellent review articles that are referenced in the 
appropriate sections.  
Chapter Two includes a description of the Materials and Methods used in our 
investigation, while Chapter Three details our findings with regard to the role of Trim58 in 
erythropoiesis. Chapter Four summarizes our findings and proposes experiments for to 
continue our investigation of Trim58 biology.  
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An overview of the importance of erythropoiesis 	  
The importance of red blood cell function 
Mature red blood cells (erythrocytes) contain an incredibly high concentration 
(~340 mg/ml, ~5.2 mM) of the heterotetrameric protein hemoglobin (Hb). Hb is directly 
responsible for binding oxygen (O2), so abundant Hb enables erythrocytes to perform 
their main function; efficiently delivering O2 to tissues throughout the body. Vertebrate 
cells rely on large quantities of O2 to generate energy in the form of adenosine 
triphosphate (ATP), thus permitting optimal aerobic tissue function.  
But why do we need erythrocytes to carry and deliver O2? The solubility of O2 in 
water is only ~0.3 mM at 20 ˚C and 1 atmosphere pressure. Without erythrocytes, the 
quantity of O2 dissolved in plasma would never be high enough to fully oxygenate 
tissues. Consequently, almost all vertebrates (with the exception of certain arctic fishes 
(Ruud, 1954)) have evolved heme-based O2 transport systems to raise the concentration 
of O2 in blood. Heme is a heterocyclic porphyrin molecule that directly coordinates iron, 
which in turn provides a docking site for an O2 molecule. Left in isolation, however, an 
oxygenated heme moiety is prone to chemical oxidation that produces harmful reactive 
O2 species. Globin proteins protect the heme iron moiety from chemical perturbations. 
Globins also augment O2 delivery by making the heme-O2 interaction reversible through 
allosteric regulatory mechanisms. We have recently reviewed the biochemical structure 
and function of normal and variant Hb molecules (Thom et al., 2013). Interestingly, free 
Hb normally degrades nitric oxide in the bloodstream to regulate vascular contractility 
(Straub et al., 2012). During hemolysis, however, too much free Hb can alter blood 
pressure control. Thus, erythrocytes sequester Hb to prevent this from happening.  
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Hb is composed of two α- and two β-like subunits (i.e., α2β2), each coordinated to 
a heme. Each heme binds one O2 molecule, so each Hb tetramer can bind up to four. 
The high concentration of Hb in blood (~5.2 mM Hb tetramer, thus ~21 mM heme), and 
the fact that red cells account for ~45% of total blood volume (~5 million erythrocytes per 
mL (Dzierzak and Philipsen, 2013)), gives a theoretical blood O2 concentration of ~9 
mM. This is roughly equivalent to the levels of O2 in the air we breathe.  
 
The importance of red blood cell shape and size 
Erythroid development is incredibly specialized to meet the unique demands and 
functions of erythrocytes. In order to physically deliver O2 to tissues, erythrocytes must 
be durable and distensible enough to withstand shear stress in the bloodstream and 
repeated passages through tiny capillaries, which can be about half the size of a mature 
erythrocyte (Keerthivasan et al., 2011). Evolutionary adaptations have augmented the 
ability of red cells to make such repeated journeys through the microvasculature by 
enhancing their durability and reducing their size (Boylan et al., 1991; Gaehtgens et al., 
1981a; Gaehtgens et al., 1981b; Hawkey et al., 1991). 
The durability of red cells is dependent on a complex array of specialized 
cytoskeletal membrane proteins that includes a Spectrin-based lattice structure as well 
as Actin, Adducin, and other proteins (Da Costa et al., 2013; Nans et al., 2011). 
Mutations in erythrocyte membrane proteins alter their mechanical stability, leading to 
hemolysis and anemia. Common examples of such disorders include hereditary 
spherocytosis and hereditary elliptocytosis, named for the abnormal shapes of the 
patient’s erythrocytes (Da Costa et al., 2013). These have been linked with mutations in 
several important erythrocyte cytoskeletal components (Da Costa et al., 2013).  
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Many species’ erythrocytes also have a circumferential “marginal band” of 
bundled microtubules that helps to maintain their shape and stability (Monaco et al., 
1982; Trinczek et al., 1993), particularly under osmotic stress (Joseph-Silverstein and 
Cohen, 1984). Interestingly, adult mammalian erythrocytes do not have marginal bands 
(van Deurs and Behnke, 1973), although camels provide an exception to this statement 
(Long, 2007). Marginal bands in Camelidae erythrocytes have been hypothesized to be 
beneficial since ellipsoid erythrocytes are able to move through thick blood encountered 
in these species during dehydrationi (Long, 2007).  
Decreased erythrocyte size can also enhance tissue O2 delivery, since small 
erythrocytes are better able to navigate our microvasculature. Small erythrocytes also 
have an increased surface area-to-volume ratio, which increases the theoretical O2 
exchange capacity of the blood. Perhaps for these reasons, there seems to have been 
evolutionary selection for organisms to have large numbers of tiny erythrocytes (Hawkey 
et al., 1991). In a survey of 441 species, mammals and birds had roughly equivalent 
amounts of hemoglobin and packed red cell volumes in their blood (Hawkey et al., 
1991). The mean corpuscular hemoglobin concentration for mammals was 34.7±2.8 
g/dL versus 33.5±2.5 g/dL for birds. However, there were stark differences in the sizes 
and numbers of erythrocytes. The average size of a mammalian erythrocyte was about 
one third the size of an average bird erythrocyte (62.1±22.2 fL compared to 168.9±28.5 
fL for birds), and mammalian erythrocyte counts were three times that of birds 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  i	  There is a common misconception that camel erythrocytes are nucleated. They are indeed 
anucleate, but different from other mammalian erythrocytes in that some of their erythrocytes 
(~3%) retain a marginal band and, perhaps as a result, are ellipsoid in shape (Cohen, W.D., and 
Terwilliger, N.B. (1979). Marginal bands in camel erythrocytes. J Cell Sci 36, 97-107.)  
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(7.77±2.86 x1012 cells/L versus 2.79±0.53 x1012 cells/L for birds). An inverse relationship 
between red cell size and volume was also evident within animal classes, presumably to  
keep total Hb content consistent (Boylan et al., 1991; Hawkey et al., 1991). Altered cell 
morphology (i.e., cell shrinkage) and enucleation are two ways that mammalian 
erythrocytes can become so small (see Section entitled Erythroid maturation). 
 
The importance of studying red blood cell development 
The genes and biochemical processes that govern erythropoiesis are of 
considerable medical interest. Defective red blood cell formation or function can cause 
anemia, a condition that affects an estimated one-quarter of the world’s population with 
huge ramifications on health and economic interests (Balarajan et al., 2011). The causes 
of anemia are multifactorial, including socioeconomic factors leading to dietary iron 
deficiency (Balarajan et al., 2011). This limits erythropoiesis since large amounts of iron 
are required to support normal erythrocyte production.  
Several heritable anemias have also been described, such as the congenital 
dyserythropoietic anemias (CDA). CDA disorders are characterized by varying degrees 
of anemia and morphological identification of multinucleated erythroblasts in the bone 
marrow (Iolascon et al., 2012; Iolascon et al., 2011). Nucleated and/or multinucleated 
erythroblasts can also be observed in circulation. CDA pathology is linked with iron 
overload, as iron intake is increased due to inappropriate suppression of hepcidin, a 
hormone that normally suppresses iron absorption (Tamary et al., 2008). Currently, 
treatment for these disorders consists of blood transfusions, iron chelation, 
hematopoietic stem cell transplant or, in the case of CDA type I, interferon therapy 
(Renella and Wood, 2009). Novel therapeutics would greatly reduce the toxicity 
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associated with these therapeutic modalities. Causative genes have been linked with all 
classical variants of this disease, including Codanin I for CDA type I (Dgany et al., 2002), 
SEC23B for CDA type II (Schwarz et al., 2009), MKLP1/KIF23 for CDA type III (Liljeholm 
et al., 2013b), and GATA1 (Nichols et al., 2000) and KLF1 (Arnaud et al., 2010) for 
“variant type” CDA. The mechanistic basis for these diseases remains unclear, although 
KIF23 regulates mitosis through its activity within the centralspindlin complex (White and 
Glotzer, 2012). This suggests that defective cell division could play some role in CDA III 
pathogenesis (Traxler and Weiss, 2013). 
Ultimately, the pathogenesis of anemia involves decreased erythrocyte 
production relative to destruction. A better understanding of normal and diseased 
erythrocyte development might improve treatment or facilitate discovery of novel 
therapeutics for these conditions. 
Mammalian erythrocytes are anucleate. Investigations specifically aimed to better 
understand the process by which mammalian erythroblasts eliminate their nuclei have 
important technical and medical applications. There is a chronic shortage of transfusable 
packed red blood cells in many parts of the world (Anstee et al., 2012; Migliaccio et al., 
2012). The generation of erythrocytes in vitro holds promise for vastly increasing the 
supply of transfusable blood, but these efforts are hindered by inefficient enucleation in 
culture (Lapillonne et al.; Peyrard et al., 2011). Novel insights into erythroid enucleation 
will be necessary to overcome this obstacle. Recent technological advances in cultured 
primary murine erythroblasts have allowed groups to study enucleation under 
experimentally controlled conditions (Koury et al., 1988; Yoshida et al., 2005; Zhang et 
al., 2003). This has enabled the identification of numerous genes and processes that 
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contribute to enucleation (see Subsection entitled Enucleation), including the work 
presented in this thesis.   
 
An overview of erythropoiesis 
 
Ontogeny of erythropoiesis 
The morphology and globin gene expression profile of a given erythrocyte 
depends on the timing and location of its development. There are, in fact, two types of 
erythropoiesis that share many aspects of development but can be delineated based on 
morphology (essentially, differences in erythrocyte size) and by the type of Hb they 
contain.  
“Primitive” erythropoiesis occurs in utero and yields macrocytic, nucleated (or 
sometimes anucleate (Fraser et al., 2007)) red cells that express embryonic globin 
genes and contain Hbs Gower 1 (ζ2ε2), Gower 2 (α2ε2), Portland 1 (ζ2γ2), and Portland 2 
(ζ2β2). “Definitive” erythropoiesis begins at mid-gestation and continues post-natally, 
yielding small, anucleate erythrocytes. Definitive erythrocytes initially contain high levels 
of fetal Hb (α2γ2, HbF) in late gestation through birth. HbF levels gradually decline to 
~1% after the first six months of life in favor of HbA (α2β2, 97%) and a small amount of 
HbA2 (α2δ2, 2%). The purposes for globin gene “switching” from HbF to HbA likely 
include, but are not limited to, in utero exchange of O2 with maternal blood (Bard et al., 
1998). HbF has higher O2 affinity than HbA. This thesis investigated definitive erythroid 
maturation. 
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The anatomical site of erythropoiesis changes throughout development in a 
sequential fashion from the yolk sac to the fetal liver, and ultimately the bone marrow 
(reviewed in (McGrath and Palis, 2008)). Under normal circumstances, the bone marrow 
is the site of all erythropoiesis ex utero, although the liver and spleen can serve as 
extramedullary erythropoietic organs in stress situations. Definitive erythropoiesis begins 
in the fetal liver around mid-gestation. In a mouse, this occurs ~12 days post-conception 
(McGrath and Palis, 2008). 
In adult bone marrow, erythroblasts mature in “erythroblast islands” surrounding 
a central macrophage (Billat, 1974; Sjogren and Brandt, 1974). Specialized interactions 
between developing erythroblasts and macrophages facilitate erythroblast proliferation, 
differentiation, and enucleation (Hanspal and Hanspal, 1994; Hanspal et al., 1998; Lee 
et al., 2003; Mankelow et al., 2004; Sadahira et al., 1995; Soni et al., 2006; Yoshida et 
al., 2005). Macrophages phagocytose expelled nuclei and use DNase II activity to 
degrade them (Kawane, 2001; Socolovsky, 2013; Soni et al., 2006). For some time, it 
was thought that erythroblast-macrophage interactions, or at least interactions with 
stromal factors like fibronectin, were necessary to promote enucleation (Patel and 
Lodish, 1987). However, the achievement of enucleation of macrophage- and stroma-
free systems has revised this view (Yoshida et al., 2005; Zhang et al., 2003). I used 
cultured definitive erythroblasts from murine fetal livers to model erythropoiesis in 
stroma-free conditions during the course of this thesis.  
 
Erythroid maturation 
All definitive erythroid cells are derived from hematopoietic stem cells (HSCs) 
(Dzierzak and Philipsen, 2013). HSCs proliferate and differentiate to give rise to all the 
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blood lineages (see for example (Orkin and Zon, 2002)), including the erythroid lineage 
(Koury et al., 2002). The process of lineage commitment remains controversial and 
multiple models exist, but the process by which committed erythroid progenitor cells 
mature into erythrocytes has been confirmed in remarkable detail (summarized in 
(Dzierzak and Philipsen, 2013; McGrath and Palis, 2008)).     
Once differentiated and committed to the erythroid lineage, so called “burst-
forming unit” (BFU-Es) precursors begin to express erythropoietin receptor (EpoR) and 
reach maximal EpoR expression by the time they become “colony-forming units” (CFU-
Es) (Sawada et al., 1990), which are dependent on erythropoietin signaling for survival 
(Wu et al., 1995). The name “burst forming unit” derives from the large colonies, 
containing several thousand hemoglobinized cells, that “burst” from these immature, 
motile precursor cells when cultured on methylcellulose (Dzierzak and Philipsen, 2013). 
CFU-Es, which are slightly more mature, yield smaller colonies of 16-125 cells.  
These committed erythroblast precursors then undergo the dramatic alterations 
in gene expression and morphology described below as they develop further into 
mature, O2-carrying erythrocytes.  
 
Altered gene expression 
The “master” erythroid transcriptional regulators GATA1 and SCL/TAL1 direct 
erythroid maturation through transcriptional induction of erythroid lineage-specific genes 
and repression of alternate lineage genes (Cheng et al., 2009; Kingsley et al., 2013; 
Welch et al., 2004). The erythroid lineage-specific set of genes are largely established 
early in development (Kingsley et al., 2013), and maintained through subsequent cell 
divisions in part through GATA1-mediated mitotic bookmarking (Kadauke et al., 2012). 
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Global DNA demethylation occurs at the onset of erythroid maturation and may provide 
a “blank slate” upon which to direct transcription of erythroid-specific genes (Shearstone 
et al., 2011). The erythroid transcriptional program includes globin genes. General 
paradigms for long-range cis-regulatory chromatin interactions, including “chromatin 
looping,” have been established through the study of the well-characterized β globin 
locus and enhancer regions (Deng et al., 2012).  
Publicly available microarray gene expression databases from human 
(Merryweather-Clarke et al., 2011) and murine erythroblasts (Kingsley et al., 2013) that 
were FACS-purified at different developmental stages based on cell surface markers, 
provide valuable resources to characterize transcriptional patterns for genes of interest 
in multiple species.   
 
Altered cell cycles and cell morphology  
Dramatic changes in appearance enable stratification of erythroid precursors into 
discrete stages of development. From the CFU-E stage, cells undergo 4-5 cell divisions 
that sequentially yield morphologically distinct basophilic erythroblasts, polychromatic 
erythroblasts, orthochromatic erythroblasts, and ultimately anucleate reticulocytes 
(Dzierzak and Philipsen, 2013; Keerthivasan et al., 2011). Basophilia correlates with the 
presence of abundant cytoplasmic ribosomes, which stain purple by Giemsa stain. 
These ribosomes are used to translate large amounts of globin (and other proteins), 
which yields the pink or gray cytoplasmic coloration seen by May Grunwald-Giemsa 
staining in later stage polychromatic and orthochromatic erythroblasts. These 
morphologic changes can be viewed as preparation for enucleation and ultimately 
erythrocyte functionality.  
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Each cell division during erythroid maturation yields two cells with decreased size 
as a result of specialized cell cycles (Keerthivasan et al., 2011; Koury et al., 1988). 
Shortened G1 phases allow maturing erythroblasts to physically shrink with each 
division, since they do not have opportunity to double in size prior to dividing (Dolznig et 
al., 1995; Grebien et al., 2005). Cyclin D3, one of three D-type cyclins that regulate G1-S 
progression (Malumbres and Barbacid, 2009; Sherr and Roberts, 2004), regulates these 
specialized cell divisions (Sankaran et al., 2012). Cultured erythroblasts treated with 
Cyclin D3-directed shRNAs demonstrated reduced numbers of divisions during 
development. Without the opportunity to divide and shrink, mature erythrocytes were 
macrocytic and reduced in number. Indeed, Cyclin D3 knockout mice have macrocytic 
erythrocytes, and humans that inherit genetic polymorphisms that diminish activity at the 
Cyclin D3 promoter demonstrate altered erythrocyte size and number (Ganesh et al., 
2009; Soranzo et al., 2009).  
Recently, erythroblast cell cycle progression was linked with transcription factor 
activities and lineage-specific gene expression, forming a “synchromesh” to coordinate 
erythroid maturation events with the cell cycle clock (Pop et al., 2010). The need for 
such a mechanism highlights the dramatic transcriptional and morphologic changes that 
must occur simultaneously within rapid cell divisions during erythroid maturation.  
Following these specialized cell divisions, orthochromatic erythroblasts undergo 
Retinoblastoma (Rb)-, E2F-, and cyclin dependent kinase inhibitor (CDK inhibitor)-
dependent cell cycle exit (Dirlam et al., 2007; Pop et al., 2010; Sankaran et al., 2008; 
Zhu and Skoultchi, 2001). Thus, further maturation events, including enucleation, occur 
in post-mitotic orthochromatic erythroblasts.  
 
	  	  	  
12 
Nuclear condensation 
During late erythroid maturation, large, active nuclei are transformed into 
condensed, transcriptionally attenuated “viscoelastic balls” (Dr. Harvey Lodish, 
Whitehead Institute, personal communication). Defective chromatin condensation 
inhibits enucleation (Ji et al., 2010; Popova et al., 2009), suggesting that an 
orthochromatic erythroblast is only able to efficiently expel a small, condensed nucleus. 
Chromatin condensation and nuclear shrinkage are facilitated by large-scale epigenetic 
changes, including histone deacetylase 2 (HDAC2)-mediated histone deacetylation (Ji et 
al., 2010; Popova et al., 2009). Downregulation of c-Myc is also necessary for this 
process. Enforced Myc expression prevented histone deacetylation and condensation 
during erythropoiesis (Jayapal et al., 2010), and the c-Myc antagonist Mxi1 (MAX-
interacting protein 1) is induced during erythroid development (Zhang et al., 2011). Mxi1 
is a target for miR-191; silencing of this microRNA during late erythropoiesis upregulates 
Mxi1 (as well as an atypical protein kinase RIO kinase 3 (Riok3)) to facilitate nuclear 
condensation (Zhang et al., 2011).  
Some of the proteins that enact chromatin condensation are present in virtually 
all cell types, whereas others are erythroid-specific. The latter include Mature 
Erythrocyte Nuclear Termination (MENT) stage specific protein, which regulates 
chromatin condensation and nuclear collapse in chicken erythroblasts (Grigoryev et al., 
1992), as well as Mxi1 and Riok3, which are enriched in late stage mammalian 
erythroblasts (Wu et al., 2009; Zhang et al., 2011). There likely remain unidentified 
erythroid-specific factors that facilitate erythroblast nuclear condensation as well.  
 
	  	  	  
13 
Enucleation 
Following the maturation processes described above, mammalian orthochromatic 
erythroblasts undergo separation of the condensed nucleus and cytoplasm in a process 
called enucleationii. The expelled nucleus, ensheathed in a thin rim of cytoplasm, is 
called a pyrenocyte (McGrath et al., 2008). Pyrenocytes are rapidly degraded within 
macrophages in the bone marrow following their formation (Soni et al., 2006). 
Meanwhile, the cytoplasm from the orthochromatic erythroblast becomes the nascent 
reticulocyte, which is released from the bone marrow and ultimately becomes a mature 
erythrocyte.  
Erythroid enucleation theoretically provides several evolutionary benefits. 
Enucleation is thought to enhance erythrocyte transit through small capillaries since 
anucleate erythrocytes are smaller (Gaehtgens et al., 1981a; Gaehtgens et al., 1981b). 
As previously described, having many small erythrocytes also increases the overall 
surface area available for O2 transfer (Gaehtgens et al., 1981a; Gaehtgens et al., 1981b; 
Hawkey et al., 1991). An additional benefit may be that anucleate erythrocytes cannot 
undergo malignant transformation (Ney, 2011).  
 For some time, the process by which erythroblasts enucleate has been 
controversial. Apoptosis-like processes facilitate enucleation in epithelial cells from the 
ocular lens and skin keratinocytes (Ishizaki et al., 1998; Nagata, 2002). These 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ii	  Although typically thought of as a mammalian-specific phenomenon, sparse examples of non-
mammalian species with anucleate erythrocytes exist as well. For instance, five clades within the 
Plethodontae family of salamanders have anucleate erythrocytes. This seems to correlate with 
small body forms and large genome size (Mueller, R.L., Gregory, T.R., Gregory, S.M., Hsieh, A., 
and Boore, J.L. (2008). Genome size, cell size, and the evolution of enucleated erythrocytes in 
attenuate salamanders. Zoology (Jena) 111, 218-230.). These observations suggest that while 
we have good theoretical reasons for why mammalian erythroblasts enucleate, we may not yet 
comprehend the whole purpose for this phenomenon.	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observations led to the hypothesis that similar mechanisms could regulate erythroblasts 
enucleation. However, caspase-mediated apoptosis does not regulate enucleation 
(Carlile et al., 2004; Krauss et al., 2005; Yoshida et al., 2005), although non-apoptotic 
caspase-3 activities are required for other aspects of terminal erythropoiesis (Boehm et 
al., 2013; De Maria et al., 1999; Ribeil et al., 2007; Sztiller-Sikorska et al., 2009; Zeuner 
et al., 2003). Instead, the currently prevailing model for erythroblast enucleation involves 
a specialized asymmetric cell division. This is supported through the observations 
detailed below.  
The physical events that occur during enucleation were described through 
electron microscopic studies dating back to the 1960s (Eitan et al., 1976; Repasky and 
Eckert, 1981; Simpson and Kling, 1967; Skutelsky and Danon, 1970). Evident physical 
processes from published images included nuclear condensation, polarized movement 
of the condensed nucleus toward the side of the cell, extrusion of the nucleus from the 
spherical boundaries of the cytoplasm, cleavage furrow-like cell membrane contraction 
at the boundary between the polarized nucleus and cytoplasm, and vesicle deposition at 
this boundary that seems to coincide with separation of the two (Figure 1.1A).  
These enucleation events largely parallel those that occur during normal mitotic 
cell division from anaphase through cytokinesis (Figure 1.1B) (Barr and Gruneberg, 
2007; Eggert et al., 2006; Fededa and Gerlich, 2012). Successful cell division requires 
sequential microtubule-dependent chromosome movement during anaphase, followed 
by GTPase-dependent contractile actomyosin ring (CAR) formation, cleavage furrow 
ingression, and lipid-containing vesicle deposition within the midbody during telophase to 
facilitate daughter cell separation. The observation that pyrenocytes contain a thin rim of 
cytoplasm is consistent with this cytokinesis-like model for enucleation (Keerthivasan et 
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al., 2011). However, one notable difference is that mitotic cells undergo nuclear 
envelope breakdown and reformation, whereas condensed erythroid nuclei remain intact 
throughout the process. The studies described below used in vitro erythroblast culture 
and in vivo mouse models to demonstrate that mitosis-related proteins and processes 
contribute to enucleation. 
 
Figure 1.1. Many events during enucleation parallel those that occur during mitosis.  
(A) During erythroblast enucleation, nuclei (gray) are sequentially condensed, polarized, and 
extruded in preparation for enucleation from the hemoglobinized cytoplasm (red). Nuclear 
polarization is dependent on microtubule (MT)-based movement (Konstantinidis et al., 2012b; 
Wang et al., 2012). Microtubules, shown in green, emanate from the MTOC (green dot). Nuclear 
extrusion depends on formation of a contractile actomyosin ring (CAR) and actomyosin-based 
cleave furrow ingression (Ji et al., 2008; Konstantinidis et al., 2012b). Vesicle deposition at the 
boundary between nucleus and cytoplasm facilitates separation (Keerthivasan et al., 2010). (B) 
During mitosis, microtubules (green) facilitate condensed chromosome (gray) alignment at 
metaphase and chromosome separation at anaphase (reviewed in (Fededa and Gerlich, 2012)). 
CAR formation and actomyosin-based cleavage furrow ingression generate a midbody, 
containing bundled bipolar microtubules, at telophase. Nuclear envelopes, which are 
disassembled during prophase, are reformed at this stage. Vesicle deposition at the midbody 
facilitates abscission between daughter cells. Note that cell sizes are not drawn to scale.  
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One of the first obvious commitments of an erythroblast to enucleation is the 
polarized movement of a condensed nucleus toward the side of the cell. At this stage of 
enucleation, the cell remains spherical. Erythroblasts treated with colchicine or 
nocodazole to depolymerize microtubules show reduced polarization (Konstantinidis et 
al., 2012b; Wang et al., 2012). Sustained microtubule polymerization with taxol resulted 
in thickened microtubule bundles around the nucleus, although polarization was not 
measured (Konstantinidis et al., 2012b; Koury et al., 1989). Enucleation was inhibited in 
response to microtubule polymerization or depolymerization. Together, these findings 
implicate dynamic microtubule-based activities in nuclear polarization and enucleation 
(see Section entitled Microtubules, molecular motor proteins, and nuclear movement).  
Microtubule-based activities function at least in part by regulating PI3K signaling 
in enucleating erythroblasts. PI3K normally regulates cell polarization in migrating cells, 
and direct chemical PI3K suppression using the compound LY294002 inhibited 
polarization (Wang et al., 2012). Nocodazole treatment also inhibited PI3K signaling 
(and nuclear polarization), as evidenced by the improper localization of downstream 
PI3K targets (Wang et al., 2012).  
The next phase of enucleation involves nuclear extrusion from the spherical 
confines of the cytoplasm. Nuclear extrusion results from CAR-mediated cleavage 
furrow-like ingression at the pyrenocyte-reticulocyte boundary (Ji et al., 2008; Koury et 
al., 1989; Repasky and Eckert, 1981; Skutelsky and Danon, 1970). Similar to mitosis, 
the CAR is set up through the actions of Rac GTPases (Ji et al., 2008; Konstantinidis et 
al., 2010; Konstantinidis et al., 2012b) and the GTPase effector protein mDia2 
(Diaphanous-related formin), which nucleates unbranched actin filaments (Ji et al., 
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2008). Actin can be visualized at the point of ingression (Ji et al., 2008; Koury et al., 
1989; Wickrema et al., 1994; Xue et al., 1997). Time-lapse microscopy indicates that 
CAR-mediated contraction is responsible for extrusion of the polarized nucleus (Ji et al., 
2008; Wang et al., 2012). Inhibition of actomyosin contraction with the small molecule 
blebbistatin inhibits nuclear extrusion (Wang et al., 2012).  
During extrusion, the distance between the nucleus and centrosome/microtubule 
organizing center (MTOC) increases (Wang et al., 2012). This suggests that the nucleus 
is not tethered to the MTOC, but instead might be “pushed” away from the MTOC at this 
stage of enucleation (see Section entitled Microtubules, molecular motor proteins, and 
nuclear movement). 
Abscission, or separation, of the pyrenocyte and reticulocyte is then achieved 
through the trafficking and deposition of lipid raft-containing vesicles. During normal cell 
division, such vesicles are thought to provide additional membrane at the site of 
daughter cell separation (Fededa and Gerlich, 2012). Clathrin facilitates normal cell 
division in multiple ways, including vesicle generation via endocytosis (Smith and 
Chircop, 2012). Erythroblasts treated with clathrin-targeted siRNAs or small molecules 
that inhibit vesicle trafficking showed inhibited enucleation (Keerthivasan et al., 2010).  
While multiple aspects of enucleation parallel cytokinesis, some studies have 
called into question how closely these processes are associated. CAR-based activities 
have been one point of contention. In one study, treatment of late stage, post-mitotic 
erythroblasts with the myosin inhibitor blebbistatin did not inhibit enucleation, as one 
might expect if constriction between cytoplasm and pyrenocyte were actomyosin-based 
(Keerthivasan et al., 2010). However, this is in direct conflict with more recent studies 
showing inhibited enucleation following blebbistatin treatment (Wang et al., 2012). The 
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reason for this discrepancy may be that cells were treated at different maturation stages 
in these studies. 
Additionally, the roles of GTPases remain unclear. Rac and Rho GTPases 
regulate cytokinesis, cell cycle progression, and actin cytoskeletal functions (Schwartz, 
2004). The downstream RhoA target ROCK phosphorylates myosin regulatory light 
chain (MRLC) to stimulate actomyosin contractility. MRLC exhibits a striking localization 
at the “back end” of polarized erythroblasts during enucleation (Wang et al., 2012). 
Although data presented in abstract form suggest that RhoA activity may be required for 
some aspect(s) of this process (Konstantinidis et al., 2012a), several previous studies 
did not identify a role for RhoA or its downstream targets in enucleation (Bement et al., 
2005; D'Avino et al., 2005; Glotzer, 2005; Wadsworth, 2005).  
Other normal mitotic processes seem to be absent during erythroblast 
enucleation, or at least have not yet been elucidated. Although the chromosomal 
passenger complex (CPC) protein Survivin is important for enucleation, it did not 
coimmunoprecipitate with other CPC proteins, like Aurora B, in enucleating erythroblasts 
(Keerthivasan et al., 2012). Instead, it co-localized with epidermal growth factor receptor 
substrate 15 and clathrin, presumably to mediate endocytic vesicle trafficking. This 
suggests that some normal mitotic processes and some erythroid-specific alterations to 
normal mitotic machinery are required for enucleation. Finally, there has not yet been a 
report detailing a midbody-like structure in enucleating erythroblasts, which would be 
expected if enucleation proceeds through a telophase-like state prior to enucleation. 
Electron micrographs do, however, hint at the presence of such a structure (Skutelsky 
and Danon, 1970). 
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Overall, recent studies of erythroid enucleation have elucidated roles for several 
molecules that facilitate mitosis and/or cytokinesis in most cell types. Parallels with 
normal cell division are certainly warranted, and the inconsistencies noted above may 
indicate specialized erythroid adaptations of cytokinetic machinery. Specialized mitoses 
late in erythroid development may underlie the pathology seen in some erythroid-specific 
diseases, such as CDA. Our laboratory and others have used genetic tools to identify 
erythroid-specific factors that regulate enucleation (see Section entitled Genetic tools 
can identify novel regulators of erythropoiesis & enucleation). 
 
Reticulocyte maturation 
Following enucleation, reticulocytes leave the bone marrow and enter the 
peripheral circulation, where they undergo substantial remodeling in order to achieve a 
characteristic biconcave shape (Coulombel et al., 1979; Mel et al., 1977). Reticulocyte 
maturation involves autophagic degradation of all remaining ribosomes, mitochondria, 
and other membrane-bound organelles, as well as exocytosis of substantial amounts of 
lipid and membrane (reviewed in (Ney, 2011)). These morphologic changes are 
important for erythrocyte functionality. Several canonical autophagy components are 
induced during erythropoiesis (Kang et al., 2012), and autophagic machinery is retained 
in reticulocytes to facilitate remodeling. Erythroid-specific autophagy factors also 
participate reticulocyte maturation, including the BCL2-related protein Nix that regulates 
mitochondria autophagy (“mitophagy”) (Schweers et al., 2007). 
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Microtubules, molecular motor proteins, and nuclear movement 
Microtubules are cylindrical filaments composed of polymerized heterodimeric α- 
and β-tubulin subunits that form a cytoskeletal network within cells (Mandelkow and 
Mandelkow, 1989). Microtubules are polarized structures that extend from a “minus end” 
toward a dynamically growing or shrinking “plus end”. In interphase cells, the minus ends 
of microtubules typically reside at the perinuclear centrosome, or microtubule-organizing 
center (MTOC), while plus ends often extend peripherally to the cell membrane.  
The polarized structure of microtubules facilitates directional intracellular 
transport. Dynein and kinesin family motors are generally thought to facilitate 
unidirectional minus end- or plus end-directed movements, respectively. These 
molecular motors facilitate many biological processes through transport of vesicles 
(Hendricks et al., 2010), autophagosomes (Maday et al., 2012), mitochondria (Tanaka et 
al., 1998), and other membrane-bound compartments and organelles (Hirokawa, 1998; 
Moughamian et al., 2013).  
Microtubule-based activities have been specifically implicated in nuclear 
polarization (Konstantinidis et al., 2012b; Wang et al., 2012) and perhaps nuclear 
extrusion (see Subsection entitled Enucleation) (Wang et al., 2012). These findings 
indirectly implicate microtubule motor proteins in enucleation, although prior to our work 
the roles of dynein or kinesins had never been investigated in enucleating erythroblasts. 
However, dynein and kinesins regulate nuclear movement in many cell types 
(Fridolfsson and Starr, 2010; Splinter et al., 2010; Tsai et al., 2007; Tsai et al., 2005; 
Tsai et al., 2010; Wilson and Holzbaur, 2012).  
In fact, nuclear movement and asymmetric positioning are seen in many 
organisms and tissues (Gundersen and Worman, 2013). One commonly studied 
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example is the neuroepithelial cell nucleus, which undergoes “interkinetic nuclear 
migration” (i.e., altered nuclear positioning) as a function of the cell cycle (Spear and 
Erickson, 2012a, b). Nuclei in these cells are typically found in a polarized position 
toward the basal side of the cell at interphase, but undergo mitosis at the apical side 
near the centrosome/MTOC. Dynein recruitment to the nuclear pores directs apical 
transport and promotes cell cycle progression (Hu et al., 2013). Although the true 
purpose for this phenomenon is unclear, it may augment progenitor cell packing in the 
limited space available at the luminal (apical) border, since most nuclei are displaced 
basally (Spear and Erickson, 2012a, b).  
 
Dynein 
Dynein is the predominant minus end-directed microtubule motor protein 
eukaryotes (Holzbaur and Vallee, 1994). In interphase cells, dynein carries cargo toward 
the MTOC that normally resides near the center of the cell. Dynein cargoes include 
several cytoplasmic organelles, including endosomes, lysosomes, phagosomes, and 
Golgi bodies (Hirokawa, 1998; Hirokawa et al., 1998). It is responsible for many critical 
processes, including vesicle transport, cell migration, and multiple aspects of mitosis, 
including nuclear envelope breakdown, mitotic spindle assembly and orientation, and 
chromosome dynamics (Collins et al., 2012; Howell et al., 2001; Tanenbaum et al., 
2010; Vallee et al., 2012). Given these varied and important functions, it is not surprising 
that dynein perturbations cause disease. Dynein mutations commonly manifest as 
defective neuronal development (Harms et al., 2012; Ori-McKenney and Vallee, 2011; 
Poirier et al., 2013).  
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Dynein was initially discovered in Tetrahymena pyriformis as a protein with 
ATPase activity that was required for ciliary motility (Gibbons and Rowe, 1965). This was 
a relatively easily purified “axonemal” dynein. A cytoplasmic version of dynein, 
discovered later, demonstrated similar activity as it facilitated retrograde microtubule-
based organelle transport in neurons (Paschal and Vallee, 1987). This thesis studied 
cytoplasmic dynein-1, heretofore referred to only as dynein, although other family 
members for this protein include axonemal (ciliary or flagellar) motors and cytoplasmic 
dynein-2, which helps assemble the axoneme and participates in intraflagellar transport 
(Allan, 2011).  
Structurally, dynein is a 1.2 MD complex composed of paired heavy chains 
(DHC), intermediate chains (DIC), light intermediate chains (DLIC), and several light 
chains. Whereas DHC genes are evolutionarily conserved from algae to man (Kikkawa, 
2013), the number and identities of the associated subunits vary considerably in different 
organisms (Holzbaur and Vallee, 1994).  
DHC is an AAA+ (ATPase Associated with diverse cellular Activities) molecular 
motor that converts energy from ATP hydrolysis into microtubule-based processive 
locomotor activity. Structural studies were initially complicated by the large size (>500 
kD), but DHC crystal structures from several organisms have now been solved (Carter et 
al., 2011; Kon et al., 2012; Kon et al., 2011; Schmidt et al., 2012). The DHC protein 
consists of stalk, loop, linker and tail domains (Figure 1.2) (Cho and Vale, 2012). The 
stalk is a ~15 nm coiled coil domain with a microtubule binding domain at its tip (Gee et 
al., 1997) and protrudes from a six-membered loop structure comprised of tandem AAA 
(ATPase) domains (Burgess et al., 2004; Samso et al., 1998). The linker domain 
dynamically associates with the loop (Roberts et al., 2012; Roberts et al., 2009) and 
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functions as a force-producing motile element similar to a mechanical “lever arm” 
(Burgess et al., 2003; Kon et al., 2005; Shima et al., 2006; Vale and Milligan, 2000). The 
stalk, loop, and linker domains participate in the ATP hydrolysis-dependent 
“powerstroke” that facilitates motility (Carter, 2013). The amino-terminal tail is the most 
evolutionarily divergent domain (Holzbaur and Vallee, 1994). It facilitates DHC 
dimerization and also interacts with dynein intermediate and light intermediate chains, 
which bind other subunits and link DHC to cargo (Carter, 2013).  
 
 
Figure 1.2. Dynein structure and 
protein interactions. Dynein heavy 
chain (DHC, black) contains stalk, loop, 
and linker domains that regulate ATP-
dependent processive motility along 
microtubules (green) (reviewed in 
(Carter, 2013)). The DHC amino-
terminal tail domain interacts with dynein 
intermediate (DIC, blue) and light 
intermediate chain (pink) subunits. DIC 
carboxy-terminal WD repeats (gray) bind 
DHC (Ma et al., 1999). The DIC amino 
terminus contains a coiled coil (CC) 
domain (red) that interacts with NudE 
and dynactin (McKenney et al., 2011; 
Zimmet and Ravid, 2000), as well a 
region depicted in yellow that interacts 
with several dynein light chains (LCs) 
(Carter, 2013). Note that protein sizes 
are not drawn to scale. 
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DIC, through several carboxy terminal tryptophan-aspartic acid (WD) repeats 
motifs, interacts with the DHC amino terminal tail domain (Figure 1.2) (Ma et al., 1999). 
At the same time, DIC interacts with dynein light chain subunits and other regulatory 
factors through its amino terminus (Ma et al., 1999; Vallee et al., 2012). Free DIC is a 
disordered polypeptide, but rapidly adopts its structure and assembles into a dimer 
following dynein light chain binding (Asthana et al., 2012; Makokha et al., 2002; Mok et 
al., 2001; Nyarko and Barbar, 2011; Nyarko et al., 2004). DIC recruits a number of 
factors that regulate holodynein activities in important ways, including dynactin, NudE 
(nuclear distribution protein E), NudEL (NudE-like), and Lis1 (lissencephaly 1 protein) 
(Vallee et al., 2012). Interestingly, NudE and dynactin were recently shown to 
competitively bind to the same location on DIC, perhaps ensuring that dynein can only 
be regulated by one factor at a time (McKenney et al., 2011). 
Dynein light intermediate (LIC) and light chains (LC) functions are, in many 
cases, not well understood. Recent studies have shown that LIC1 and LIC2 regulate 
mitosis through localization at the mitotic spindle and midbody, or spindle poles, 
respectively (Horgan et al., 2011). These may recruit dynein to these sites during 
mitosis, but the separate localizations for these LIC subunits suggest that they may have 
distinct functions. In D. melanogaster, LIC regulates several dynein functions, including 
holodynein-mediated spindle checkpoint inactivation (Mische et al., 2008). LC subunits 
also regulate mitotic spindle assembly and progression (Asthana et al., 2012; Stuchell-
Brereton et al., 2011). Some LC functions, such as Tctex-1-mediated RhoGEF inhibition, 
are dependent on interactions with the holodynein complex (Meiri et al., 2012).  Other 
LC functions are holodynein-independent. For example, ectopic expression of the Tctex-
1 subunit causes defective neurite extension in a dynein-independent fashion (Chuang 
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et al., 2005). Further studies are necessary to clarify the binding partners and functions 
of LIC and LC subunits.  
Several important regulatory accessory proteins influence dynein functions. The 
multi-subunit complex dynactin stimulates dynein processivity along microtubules 
(McGrail et al., 1995), acts as an adapter protein between dynein and cargo 
(Hammesfahr and Kollmar, 2012), and inhibits microtubule catastrophe through actions 
at the plus ends of neuronal microtubules (Lazarus et al., 2013). Dynactin regulates 
dynein functions during mitosis (Quintyne et al., 1999) and organelle transport 
(Moughamian et al., 2013). Given these important functions, it is not surprising that 
dynactin mutations cause disease, including disrupted motor neuron development (Puls 
et al., 2003) and neurodegeneration (Moughamian and Holzbaur, 2012).  
Dynactin contains a coiled coil domain that directly interacts with the DIC amino 
terminal coiled coil motif (Figure 1.2) (Ma et al., 1999). DIC phosphorylation inhibits this 
interaction (Vaughan and Vallee, 1995). Ectopic expression of this domain, called CC1, 
is thought to competitively inhibit normal DIC-dynactin interactions and thereby perturb 
normal dynein functions (Quintyne et al., 1999).  
NudE/NudEL and Lis1 also regulate dynein functions. These proteins regulate 
dynein-dependent nuclear positioning (Hu et al., 2013; Shu et al., 2004; Tsai et al., 
2007), cell migration (Dujardin et al., 2003; Shen et al., 2008), chromosome alignment 
and mitotic spindle assembly (Faulkner et al., 2000; Liang et al., 2007; Siller and Doe, 
2009; Siller et al., 2005; Stehman et al., 2007; Vergnolle and Taylor, 2007). Mutations in 
these genes cause neurological diseases including congenital Lissencephaly (Alkuraya 
et al., 2011; Reiner et al., 1993). NudE binds the DIC amino terminus (Figure 1.2) 
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(McKenney et al., 2011) and Lis1 binds to the DHC motor domain loop during the pre-
powerstroke stage (Sasaki et al., 2000). 
As mentioned in the preceding paragraphs, several studies have directly 
implicated dynein in nuclear movement. In fact, defects in nuclear movement and mitotic 
spindle positioning were the first phenotypes associated with dynein deficiency in S. 
cerevisiae (Eshel et al., 1993; Li et al., 1993). Time lapse imaging of C. elegans 
suggested that dynein minus end-directed nuclear movement was necessary to bypass 
intracellular “roadblocks” on microtubules (Fridolfsson and Starr, 2010). The same is true 
in primary myoblasts, which form syncytia through nuclear migration (Wilson and 
Holzbaur, 2012). Dynein also facilitates nuclear movement toward the MTOC in U2OS 
cells. Treatment with DHC-targeted siRNA or injection of anti-DIC antibody caused 
increased distance between the nucleus and MTOC at G2/prophase, when dynein is 
recruited to the nuclear envelope (Splinter et al., 2010). In fact, dynein interactions at the 
nuclear envelope during G2 are required for cell cycle progression in neurons (Hu et al., 
2013).  
Regulatory proteins are important for dynein-mediated nuclear migration. NudE, 
Lis1, and dynein colocalize at the nuclear envelope (Bolhy et al., 2011; Hebbar et al., 
2008) and control neuronal nuclear movement via a microtubule cage-like structure that 
pulls nuclei toward the centrosome (Shu et al., 2004; Tsai et al., 2007; Xie et al., 2003). 
Concurrent binding of NudE and Lis1 induce dynein into a persistent force-producing 
state, which is important for moving large cargo like the nucleus (McKenney et al., 
2010). Dynactin, Ranbp2 (Ran binding protein 2)-Bicd2 (Bicaudal D2), Nup133 
(Nucleoporin 133)-CENPF (Centromere protein F), SUN/KASH (Sad1p, UNC-
84/Klarsicht, ANC-1, Syne Homology) domain-containing proteins, and Nesprins 
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(Nuclear envelope spectrin repeat proteins) are also involved in dynein recruitment to 
the nuclear envelope (reviewed in (Vallee et al., 2012)). 
Dynein also regulates important cellular functions through localization at the cell 
cortex. NudE/Lis1, dynactin, and other regulators like NuMA (Nuclear mitotic apparatus 
protein) colocalize with dynein at the cell cortex (Kotak et al., 2013; Moore and Cooper, 
2010; Shen et al., 2008). Its cortical positioning regulates cell migration, cell polarity, 
morphogenesis, and mitosis (Kirschner and Mitchison, 1986; Kotak et al., 2013; Moore 
and Cooper, 2010; Shen et al., 2008). Cortical dynein also stabilizes microtubule plus 
ends and prevents microtubule depolymerization (i.e., “catastrophe”) (Hendricks et al., 
2012). 
 
Kinesins 
Kinesin proteins are microtubule plus end-directed motors that carry cargo in the 
opposite direction to dynein; typically toward the cell periphery in interphase cells 
(Verhey et al., 2011). Standardized nomenclature delineates 14 families of kinesin 
molecules, with varied forms and functions (Lawrence et al., 2004). Abnormalities in 
kinesin-mediated transport have been linked to neurodegenerative diseases, polycystic 
kidney disease, and cancer (Gerdes et al., 2009; Salinas et al., 2008; Yu and Feng, 
2010).  
Structurally, all kinesins have head, neck, and tail domains. The amino-terminal 
motor head domain binds microtubules and facilitates processivity (Verhey et al., 2011). 
The neck domain includes linker and coil regions that mediate processivity and kinesin 
oligomerization. The tail domain binds kinesin light chain (KLC) proteins, which mediate 
attachment to substrates or regulatory proteins but are not necessary for kinesin motor 
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activity. In fact, the tail domain can interact with some kinesin motor domains to facilitate 
autoinhibition in the absence of cargo. In contrast to the multi-subunit holodynein 
complex, kinesins transport cargo as single proteins or homomultimers without adapter 
proteins, although kinesin light chains can provide adapter function in some 
circumstances (Verhey et al., 2011). 
Kinesin-1 proteins, otherwise known as the canonical kinesin heavy chains 
(KHC), are perhaps the most well understood kinesin family members. In mammals, the 
KIF5A, KIF5B, and KIF5C genes encode KHC proteins. Whereas KIF5A and KIF5C are 
restricted to neuronal cells, KIF5B expression is relatively ubiquitous (Xia et al., 1998). A 
KIF5B knockout mouse is embryonic lethal, but work with KIF5B-/- murine embryonic 
fibroblasts showed that KIF5B was necessary for mitochondria distribution toward the 
cell periphery (Tanaka et al., 1998). 
Plus end-directed nuclear movements were mediated by KHC in several of the 
studies (Fridolfsson and Starr, 2010; Splinter et al., 2010; Wilson and Holzbaur, 2012). 
In fact, dynein and kinesin-1 physically interact to co-regulate motor activity and mediate 
bidirectional transport (Ligon et al., 2004). However, kinesin-3 (KIF1A), which has similar 
processivity properties as kinesin-1 (Hammond et al., 2009), has also been shown to 
facilitate nuclear movement in neuronal progenitor cells (Tsai et al., 2010). It is possible 
that other kinesins can promote nuclear transport as well. 
Other kinesin proteins have varied mechanisms that extend beyond simple cargo 
transport. For instance, Kif23/Mklp-1 (Mitotic kinesin-like protein 1) regulates Rho 
GTPase activation, mitotic spindle compaction, and formation of bipolar microtubule 
arrays during telophase as part of the centralspindlin complex (White and Glotzer, 2012). 
Mutations in Kif23 cause CDA type III and result in multinucleated erythroid precursors, 
	  	  	  
29 
presumably through failed cytokinesis during erythroid maturation (Liljeholm et al., 
2013a; Traxler and Weiss, 2013). Kif20a/MKLP-2 also regulates cell division through its 
localization at mitotic spindles, which facilitates recruitment of the chromosomal 
passenger complex (Hummer and Mayer, 2009). Kif20a also regulates vesicular 
trafficking through Golgi bodies through association with Rab6 (Duden, 2001; Echard et 
al., 1998). Kif2a, another kinesin family protein, depolymerizes microtubules. Kif2a 
knockout mice show aberrant axonal branching from over-extended microtubules, which 
results in neurological dysfunction (Homma et al., 2003). Kif2a also regulates the length 
of the central spindle during mitosis by depolymerizing the distal ends of microtubules 
(Uehara et al., 2013).  	  
An overview of the ubiquitin-proteasome system 
The ubiquitin-proteasome system (UPS) utilizes a cascade of E1 ubiquitin-
activating, E2 ubiquitin-conjugating, and E3 ubiquitin-ligating enzymes to covalently link 
the small (76 amino acids, ~8.5 kD) polypeptide ubiquitin to substrates (Figure 1.3) 
(Deshaies and Joazeiro, 2009; Dikic and Robertson, 2012). Polyubiquitin chains are 
then created by covalent linkage of ubiquitin monomers through one of seven lysine 
residues (Komander, 2009). Substrate ubiquitylation can alter intracellular signaling, 
protein interactions, or allosteric regulation, or lead to degradation by the lysosome or 
26S proteasome (Deshaies and Joazeiro, 2009; Komander, 2009). Initially regarded as a 
housekeeping mechanism to destroy and recycle amino acids from damaged proteins, 
the UPS has now been centrally implicated in cell cycle regulation, intracellular transport, 
cell signaling, transcription, translation, and DNA repair (Dikic and Robertson, 2012; 
Komander, 2009; Messick and Greenberg, 2009; Pickart, 2004). 
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Figure 1.3. Schematic depiction of 
ubiquitin proteasome system activity. 
The ubiquitin-proteasome system covalently 
attaches the small polypeptide ubiquitin (Ub) 
to substrates through sequential actions of 
E1, E2, and E3 enzymes. E1 activating 
enzymes catalyze ATP-dependent chemical 
activation of ubiquitin, which is subsequently 
transferred to E2 conjugases via 
transthioesterification. RING-containing E3 
ligases simultaneously recruit E2 
conjugases, carrying activated Ub, and 
substrates through direct interactions. 
Ubiquitylation frequently targets substrates 
for proteasomal degradation.  
 
 
E3 ubiquitin ligases confer UPS target specificity by virtue of direct interactions 
with substrates. Whereas there are ~7 E1 ubiquitin activating enzymes and ~40 E2 
ubiquitin conjugases, more than 600 human E3 ubiquitin ligases exist (Deshaies and 
Joazeiro, 2009; Metzger et al., 2012). By comparison, there are only 518 known protein 
kinase genes, lending some idea of the prevalence of protein ubiquitylation as a post-
translational mechanism in cell biology.  
E3 ligases can function through one of two biochemical mechanisms, depending 
on whether they contain a HECT (Homologous to E6-AP Carboxyl Terminus) or a RING 
(Really Interesting New Gene) domain. HECT-containing E3 ligases carry activated 
ubiquitin and mediate attachment directly to substrates. In contrast, RING-containing E3 
ligases simultaneously recruit E2 conjugases (carrying activated ubiquitin) and 
substrates, facilitating ubiquitin transfer by proximity (Figure 1.3).  
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The vast majority of E3 ligases contain RING or RING-like (i.e. Plant 
homeodomain, PHD; Leukemia associated protein, LAP; or U-box) domains (Deshaies 
and Joazeiro, 2009; Metzger et al., 2012). Indeed, the mammalian genome encodes 
more than 600 putative RING E3 ligases (Li et al., 2008). The identities of both the E2 
and substrate are important when considering the function(s) of a RING E3 ligase, since 
the recruited E2 conjugase directs both the type of polyubiquitin linkage (Deshaies and 
Joazeiro, 2009; Metzger et al., 2012) and can alternatively carry activated ubiquitin-like 
SUMO, Nedd, or ISG moieties (Dikic and Robertson, 2012; Metzger et al., 2012; 
Napolitano and Meroni, 2012).  
 
Tripartite motif-containing proteins are putative RING E3 ubiquitin ligases 
The Trim (Tripartite motif-containing) proteins comprise the largest family of 
RING-containing putative E3 ligases (Marco Sardiello, 2008; Meroni and Diez-Roux, 
2005; Napolitano et al., 2011; Napolitano and Meroni, 2012), with more than 65 
members identified in human cells (Meroni and Diez-Roux, 2005; Versteeg et al., 2013). 
Trim proteins function broadly in physiology and disease states (Napolitano and Meroni, 
2012). Their prominent roles in developmental biology (Petrera and Meroni, 2012), 
oncogenesis (Hatakeyama, 2011), transcriptional regulation (Cammas et al., 2012), 
innate immunity (Ozato et al., 2008; Rhodes et al., 2005), and viral infection responses 
(Nisole et al., 2005) have been the subjects of recent review articles.  
By definition, Trim proteins contain a tripartite motif composed of a RING domain, 
one or two B-box domains, and a coiled-coil (CC) region (Figure 1.4). The presence of 
all three domains within the tripartite motif is generally thought to allow proper function, 
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Figure 1.4. Structure and function 
for common Trim protein 
domains. Trim proteins contain a 
tripartite RING-BBox-Coiled Coil 
(CC) motif (gray) linked with a 
carboxy-terminal substrate-binding 
domain which, in more than half of 
mammalian Trim proteins, is an 
immunoglobulin-like PRY-SPRY 
domain (green). Concomitant RING-
dependent E2 conjugase/activated 
ubiquitin (Ub) recruitment and PRY-
SPRY-mediated substrate binding 
can target substrates for 
proteasomal degradation. 
 
although this has not been tested on all Trim proteins and splice variants are known to 
exist (Napolitano and Meroni, 2012). The RING and BBox domains coordinate zinc ions 
through conserved cysteine and/or histidine residues. Whereas RING domains function 
to recruit E2 conjugases, the biological roles of the BBox domain(s) are significantly less 
well understood. The BBox may augment the E3 ligase activity of the RING domain (i.e., 
as an “E4” enzyme) (Kuhlbrodt et al., 2005; Massiah et al., 2006) or recruit substrates. 
For example, the Trim18/MID1 BBox domain binds and ubiquitylates the protein 
phosphatase 2A (PP2A) α4 subunit to promote its degradation (Liu et al., 2001; Short et 
al., 2002; Trockenbacher et al., 2001).  
Trim protein CC domains facilitate homo- or hetero-oligomerization of Trim 
proteins, which is generally considered necessary for proper function (Meroni and Diez-
Roux, 2005; Napolitano and Meroni, 2012). Deletion of the CC abrogates activity for 
Trim5α (Javanbakht et al., 2006) and alters binding properties for several Trim proteins 
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(Reymond, 2001). CC-mediated multimerization significantly increases the activity of 
several Trim proteins in vitro (Streich et al., 2013).  
The tripartite motif is typically linked with a carboxyl-terminal domain that recruits 
substrates or determines subcellular localization (Meroni and Diez-Roux, 2005; 
Napolitano and Meroni, 2012). Although the identity of the carboxy-terminal domain 
varies among Trim proteins, more than half of mammalian Trim proteins contain an 
immunoglobulin-like PRY-SPRY (Sp1a and Ryanodine Receptor) domain that typically 
facilitates protein interaction(s) (Rhodes et al., 2005). This domain has historically been 
referred to as a B30.2 domain or an Rfp-like (Ret finger protein-like) domain (Meroni and 
Diez-Roux, 2005; Napolitano and Meroni, 2012). Some PRY-SPRY domains recruit 
substrates for ubiquitylation and proteasomal degradation (see for example (Zhang et 
al., 2012a; Zhang et al., 2012b; Zhao et al., 2012)). While other carboxy-terminal domain 
types are functionally important for certain Trim proteins, this thesis will focus on the 
PRY-SPRY since Trim58 contains one such domain.  
The PRY-SPRY domain is evolutionarily restricted to vertebrates with an 
adaptive immune system (Rhodes et al., 2005). It is found in ~700 proteins, including 
~150 mammalian proteins across 11 different protein families (Rhodes et al., 2005; Woo 
et al., 2006a). For example, in addition to Trim proteins, the PRY-SPRY domain is also 
found in butyrophilin family proteins, which are immunoglobulin-like cell surface receptor 
glycoproteins (Rhodes et al., 2005).  
The PRY and SPRY subdomains are co-dependent for stability and function 
(D'Cruz et al., 2013). Crystallization studies show that PRY-SPRY domains contain eight 
variable loops, designated A-F, which form a substrate binding pocket with a single two-
layered β-sandwich fold at its core (see for example (D'Cruz et al., 2013; Rhodes and 
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Trowsdale, 2007; Woo et al., 2006a; Woo et al., 2006b)). The composition of these 
variable loops determines substrate identity. Structural studies demonstrated that the 
loops mediate interaction with short (<20 amino acids) sequence motifs, suggesting that 
each PRY-SPRY domain can bind multiple target substrates (Woo et al., 2006a; Woo et 
al., 2006b).  
Human pathophysiology is associated with PRY-SPRY dysfunction. For example, 
point mutations in the PRY-SPRY domains of TRIM20/Pyrin cause Familial 
Mediterranean Fever (Bakkaloglu, 2003). This autoimmune disorder is marked by 
recurrent episodes of joint and organ inflammation, most seriously affecting the kidneys 
and leading to renal failure (Shohat and Halpern, 2011). Pyrin protein normally inhibits 
inflammasome activation (Xu et al., 2013a). Defective Pyrin function causes disease via 
aberrant inflammatory pathway activation in immune cells. 
 
The role of the ubiquitin proteasome system in erythropoiesis  
The UPS serves integral functions during erythroid maturation, including the 
ubiquitylation and degradation of important erythroid proteins. In fact, the UPS was 
initially characterized in Nobel prize-winning work using rabbit reticulocyte lysate 
(Ciechanover et al., 1978; Etlinger and Goldberg, 1977; Hershko et al., 1983). During 
erythroid maturation, cells degrade much of their proteome and synthesize large 
amounts of Hb. Robust UPS activity is necessary both to degrade normal but 
unnecessary proteins, as well as misfolded or aggregated Hb subunits (Khandros et al., 
2012; Khandros and Weiss, 2010). Other UPS targets in erythroid cells include activated 
erythropoietin receptor (Walrafen et al., 2005) and cytoskeletal proteins such as actin 
and tubulin (Liu et al., 2010). Many E2 and E3 enzymes are induced during 
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erythropoiesis ((Lausen et al., 2010; Wefes et al., 1995) and our unpublished 
observations). In fact, pathway analysis of the human erythrocyte proteome identifies a 
large number of UPS-related molecules (~35% of all protein ubiquitylation pathway 
molecules as defined by Ingenuity Systems (Roux-Dalvai et al., 2008)).  
Given the important roles of the UPS in cell biology and the abundance of UPS-
related proteins in erythropoiesis, it is likely that much can be learned about erythroid 
biology by studying UPS activity in this lineage. For example, general UPS inhibition with 
the proteasome inhibitor MG132 reduces enucleation efficiency in cultured erythroblasts 
(Chen et al., 2002). However, few E3 ligases have been shown to regulate erythroid 
development. Mdm2 and Mdm4 inhibit p53 (Maetens et al., 2007), Cul4A targets the cell 
cycle inhibitor p27 (Li et al., 2006), and Fbw7-mediated cyclin E degradation (Xu et al., 
2013b) all help to control cell cycle progression during terminal erythroid maturation. 
These E3 ligases are expressed in many tissues. To our knowledge, the work presented 
in this thesis is the first illustration of a putative erythroid-specific E3 ligase that regulates 
terminal erythropoiesis through UPS activity. 
 
Genetic tools can identify novel regulators of erythropoiesis & enucleation 
The Weiss lab has previously used genetic tools to identify novel regulators of  
erythropoiesis, such as alpha hemoglobin stabilizing protein (AHSP) (Kihm et al., 2002) 
and microRNA 144/451 (Yu et al., 2010). Microarray analyses indicated that these genes 
were transcriptionally induced during erythroid development through the actions of 
important transcription factors, including Gata1 and SCL/Tal1 (Cheng et al., 2009; Welch 
et al., 2004). Through gene expression analysis of fluorescence-activated cell sorting 
(FACS)-purified primary murine erythroblasts, we identified Trim58 as a gene that is also 
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transcriptionally induced during late erythroid maturation. Gata1 and SCL/Tal1 activities 
are likely to facilitate Trim58 induction (see Chapter 3).  
Genome wide association studies (GWAS) aim to link single nucleotide 
polymorphisms (SNPs) with important human health traits. Recent GWAS have 
associated many understudied genes with altered erythrocyte size and/or count 
(Kamatani et al., 2010; Nuinoon et al., 2009; Soranzo et al., 2009; van der Harst et al., 
2012). Each of these genes potentially regulates important aspects of normal human red 
cell development. Putative and validated E3 ubiquitin ligases, including TRIM58, were 
among the genes identified. SNPs linked with TRIM58 were statistically significantly 
associated with altered red blood cell size and/or count in two GWAS (Kamatani et al., 
2010; van der Harst et al., 2012). In addition to our identification of Trim58 as an 
erythroid-regulated gene, these findings compelled us to investigate the functions of the 
previously uncharacterized Trim58 protein.  	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CHAPTER 2: MATERIALS AND METHODS 
 
A. Trim58 cloning  
The full length Trim58 gene, including 5’ and 3’ untranslated regions (UTR), was 
initially TOPO cloned into pCRII-Dual vector (Invitrogen) from murine fetal liver 
erythroblast cDNA using the following primers (Forward: 
GCCATGGCCACGGCACCCGGGG, Reverse: CAGCACTTCTGGATGGGTTT). Full 
length (wild type) Trim58 was subcloned from pCRII-Dual-Trim58 into retroviral vectors 
using the following primers to create 5’ FLAG/HA epitope-tagged constructs (Forward: 
GAAGATCTAGATCTGCCATGGACTACAAGGACGACGATGACAAATACCCATACGAC
GTCCCAGACTACGCTGCCTCAGCTCCTTCTGTG, Reverse: 
CGGAATTCCAGCACTTCTGGATGGGT). The RING-dead Trim58 construct, containing 
Cys>Ala missense mutations at residues 55 and 58 (within the RING domain), was 
created from a full length Trim58 construct using a two-step PCR method using the 
above full length Trim58 Forward and Reverse primers and the following mutation-
generating primers (Forward: GGACCCCTGGCCTGGGGTGCGGCGTAGAC, Reverse: 
GTCTACGCCGCACCCCAGGCCAGGGGTCC). The Trim58 PRY-SPRY domain, 
including residues 281-485, was subcloned from a full length Trim58 construct using the 
following primers (Forward: AGAAGATCTAGATCTGCCATGAGGGAGATG, Reverse: 
CGGAATTCCAGCACTTCTGGATGGGT). This construct begins 8 amino acids 
upstream and extends 25 amino acids downstream of the predicted PRY-SPRY domain. 
Live cell imaging plasmids were cloned into the BglII/EcoRI site of a pK1 vector 
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containing amino-terminal FLAG and carboxy-terminal mCherry tags (S. Kadauke & G. 
Blobel, Children’s Hospital of Philadelphia) using the following primers (Forward: 
GAAGATCTAGATCTATGGCCACGGCACCCG, Reverse: 
CCGGAATTCGAATTCGTATTCCTCACTTCTGGCAG).  
Trim58 constructs were cloned into the BamHI/EcoRI or BglII/EcoRI sites in several 
expression vectors for this study, including pCRII-Dual (Invitrogen), retroviral MIGR1 
(Murine Stem Cell Virus (MSCV) promoter-driven construct with downstream IRES-
GFP), retroviral pK1 (MSCV-driven construct with downstream IRES-puromycin), and 
pGEX6P1 (GE Healthcare) for GST-tagged constructs. 
 
B. Radioactive in situ hybridization  
Embryonic day 14.5 (E14.5) murine embryos were fixed, dehydrated, paraffin-
embedded, sectioned, and stained with an antisense probe targeting Trim58 nucleotides 
841-1455 per protocols from the University of Pennsylvania Molecular Cardiology 
Research Center Histology and Gene Expression Core Facility 
(http://www.med.upenn.edu/mcrc/histology_core/). 
 
C. Flow cytometry 
For fluorescence activated cell sorting of primary murine fetal liver erythroblasts, 
single cell suspensions from whole fetal livers were stained with Ter119-APC 
(BioLegend) and CD71-PE (BD Pharmingen) for 45 min at 4 °C in PBS and sorted on a 
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FACSAria instrument (BD Biosciences) per a previously described gating strategy (Pop 
et al., 2010). 
For cultured murine fetal liver erythroblast analysis, 5x105 cells were stained 
sequentially with 5 µM Hoescht33342 (Sigma) for 1 hr at 37 °C in fetal liver maturation 
medium, Live/Dead near-IR fixable dead cell stain (Invitrogen) for 30 min at 4 °C in PBS, 
and Ter119-PerCP-Cy5.5 and CD44-AF647 (BioLegend) for 45 min at 4 °C in PBS with 
2% fetal bovine serum (FBS). Cells were analyzed on an LSR Fortessa instrument (BD 
Biosciences) maintained by the Flow Cytometry Core Laboratory of The Children’s 
Hospital of Philadelphia Research Institute. Data were analyzed using FlowJo software 
(TreeStar).  
 
D. Semiquantitative real time PCR  
RNA was extracted using the RNeasy kit (Qiagen) with on-column DNAse treatment. 
cDNA was prepared using the iScript cDNA kit (BioRad). Semiquantitative real-time PCR 
was done using the standard curve method and SYBR green dye on a ViiA 7 real-time 
PCR system (Life Technologies). Real time primers used in this study probed for murine 
Trim58 (Trim58; Forward: GAGCGTCTTTGGAACTTGTG, Reverse: 
ACCCTCTGTGTTTCTCAAACTC), dynein heavy chain (Dync1h1; Forward: 
TTGTACCGCATCCAAGAGAAG, Reverse: GTTGTAGTCATTCACCGTTTCC), dynein 
intermediate chain (Dync1i2, Forward: ACAGTCAAAGGCAGTAGCTG, Reverse: 
CTGGTGTCCCTCAAACATCTC), actin (Actb; Forward: 
CCTTCCTTCTTGGGTATGGAATC, Reverse: AGCACTGTGTTGGCATAGAGGT), 
hypoxanthine guanine phosphoribosyl transferase (Hprt; Forward: 
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TCAGTCAACGGGGGACATAAA, Reverse: GGGGCTGTACTGCTTAACCAG), and 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh, Forward: 
AGGTTGTCTCCTGCGACTTCA, Reverse: CCAGGAAATGAGCTTGACAAA). Target 
gene expression was normalized to the average of Actb, Gapdh, and Hprt values. 
 
E. In silico analyses of Trim58 gene regulation and expression 
ChIP-Seq data at the murine Trim58 locus were obtained from the Penn State 
University Bioinformatics Genome Browser (https://mery.genome-browser.bx.psu.edu/). 
The data presented in Figures 3.2C and 3.23 were generated from primary fetal liver 
erythroblasts by ChIP-Sequencing and RNA-Sequencing, respectively (Pimkin et al, in 
revision). Human TRIM58 mRNA tissue expression patterns were obtained from publicly 
available microarray data (Figures 3.1A (Wu et al., 2009) and 3.1B (Novershtern et al., 
2011)). Erythroid TRIM58 expression data were obtained from microarray analysis of 
FACS-purified human erythroblasts cultured from peripheral blood buffy coat 
mononucleocytes (Figure 3.1C (Merryweather-Clarke et al., 2011)). 
 
F. Murine fetal liver erythroblast isolation 
E14.5 murine fetal livers were harvested from pregnant CD1 mice (Charles River 
Laboratories), triturated, and passed through a cell strainer (BD Biosciences) to yield 
stroma-free single cell suspensions. Erythroid progenitors were purified by negative 
selection on magnetic beads using the EasySep Mouse Hematopoietic Progenitor Cell 
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Enrichment Kit (STEMCELL Technologies) according to the manufacturer’s instructions, 
with the addition of biotin-conjugated anti-mCD71 (eBioscience).  
 
G. Short hairpin RNA cloning 
Short hairpin RNAs from pGIPZ vectors (Open Biosystems) were subcloned into the 
“PIG” (MSCV-Puromycin-IRES-GFP) retroviral vector (Hemann et al., 2003). These 
shRNA constructs are within a miR30 stem-loop structure to aid processing. Primers 
(Forward: AGATCTAGATCTTGCTGTTGACAGTGAGCG, Reverse: 
CTCGAGCTCGAGTCCGAGGCAGTAGGC) were used to clone the following shRNAs 
into the MSCV-PIG vector BglII and XhoI sites. The sense strand is indicated in red, 
antisense in blue, loop in green, and the common miR-30 context in black. 
 
shLuciferase (RHS1705) 
TGCTGTTGACAGTGAGCGCCCGCCTGAAGTCTCTGATTAATAGTGAAGCCACAGAT
GTATTAATCAGAGACTTCAGGCGGTTGCCTACTGCCTCGGA  
 
shScrambled (RHS4346) 
TGCTGTTGACAGTGAGCGATCTCGCTTGGGCGAGAGTAAGTAGTGAAGCCACAGA
TGTACTTACTCTCGCCCAAGCGAGAGTGCCTACTGCCTCGGA 
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shTrim58 #3 (V3LMM_487333) 
TGCTGTTGACAGTGAGCGACCGAGACTCAGTGCTGAGAAATAGTGAAGCCACAGAT
GTATTTCTCAGCACTGAGTCTCGGCTGCCTACTGCCTCGGA 
 
shTrim58 #4 (V3LMM_487334) 
TGCTGTTGACAGTGAGCGCCTCCTTCTACAATGTCACAAATAGTGAAGCCACAGAT
GTATTTGTGACATTGTAGAAGGAGATGCCTACTGCCTCGGA 
 
shTrim58 #5 (V3LMM_487335) 
TGCTGTTGACAGTGAGCGCTTGGACTACGAAGCTGGTGAATAGTGAAGCCACAGAT
GTATTCACCAGCTTCGTAGTCCAAATGCCTACTGCCTCGGA 
 
shTrim58 #7 (V3LMM_487337) 
TGCTGTTGACAGTGAGCGCCGGGATCTTTTTGGACTACGATAGTGAAGCCACAGAT
GTATCGTAGTCCAAAAAGATCCCGATGCCTACTGCCTCGGA 
 
H. Retroviral infection  
Retroviral PIG constructs were packaged by co-transfection of pCL-Eco into 293T 
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cells via calcium phosphate transfection. To create retrovirus for human (HeLa) cell 
infection, constructs were packaged by co-transfection of pVSVG and pCPG into 293T 
cells. Retroviral supernatants were collected 24 and 48 hr post-transfection and kept at   
-80 oC until use. Cells were infected with retroviral supernatant containing 8 µg/mL 
polybrene (Sigma) and 10 mM Hepes (Gibco) by centrifugation at 2800 rpm for 90 min at 
30 °C. 
 
I. Erythroblast culture conditions 
Our methods were based on those initially devised by Zhang et al (Zhang et al., 
2003) with some modifications. Erythroid progenitors were “expanded” for 24-72 hrs in 
StemPro-34 serum free media (Gibco) containing 10% SP34 supplement, 2 mM L-
glutamine (Gibco), 1% Penicillin/Streptomycin (Gibco), 0.1 mM 1-thioglycerol (Sigma), 1 
µM dexamethasone (Sigma), 0.5 Units/mL Erythropoietin (Amgen), and 1% mSCF-
conditioned medium. At 18-24 hrs post-infection, puromycin (1 µg/mL) was added to 
select for infected cells. Following expansion, cells were pelleted at 800 rpm for 3 min, 
washed thrice in PBS, and cultured in fetal liver maturation medium (IMDM 
(Mediatech/Cellgro), 10% BenchMark fetal bovine serum (Gemini Bioproducts), 10% 
plasma derived serum (Animal Technologies), 5% Protein Free Hybridoma Media II 
(Gibco), 2 mM L-glutamine (Gibco), 1% Pen/Strep (Gibco), 0.1 mM 1-thioglycerol 
(Sigma), and 2 Units/mL Erythropoietin (Amgen)) for up to 48 hrs. After 48 hrs, 
maturation was complete, cultures began to die, and analyses became unreliable. 
Expansion and maturation cultures were kept below 1 million cells per mL at all times. 
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J. Erythroblast morphology analysis 
Cells were centrifuged onto a glass slide and stained with May Grünwald-Giemsa 
(Sigma). Light microscopy images were obtained with a Zeiss Axioskope 2 microscope, 
Zeiss Axiocam camera, and Zeiss AxioVision 3.1 software (Carl Zeiss Microimaging) at 
room temperature. Multinuclearity was assessed by visual inspection of May Grünwald-
Giemsa-stained slides. The “Analyze Particles” feature within FIJI (Schindelin et al., 
2012) was used to quantify nuclear sizes from slide images. 
 
K. Western blot analysis 
Sample loading was normalized to protein content. Proteins were resolved on Tris-
Glycine gels (BioRad), transferred to 0.45 µm PVDF (Whatman) or Nitrocellulose 
membrane (BioRad), and blocked in 5% milk. Primary antibodies included Dynein Heavy 
Chain (R-325, Santa Cruz), Dynein Intermediate Chain (MAB #1618, Millipore), Nup153 
(QE5, Abcam), Gapdh (FL-335, Santa Cruz), α globin (custom rabbit polyclonal, 
Covance), Hemagglutinin (Y-11, Santa Cruz), FLAG (M2, Sigma), Codanin1 (G-1, Santa 
Cruz), and β actin-HRP (Sigma). Anti-Trim58 antibodies were raised against a peptide 
from the N-terminus (ERLQEEARCSVCLDFLQEPISVD) of murine Trim58 (Thermo 
Scientific). HRP-conjugated anti-mouse and anti-rabbit secondary antibodies, protein 
size markers, and other reagents were from Thermo Scientific.  
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L. Cell counting 
Cultured erythroblasts were analyzed on a C6 Accuri Flow Cytometer (BD 
Biosciences) at medium flow rate to quantify the number of GFP+ cells.  
 
M. Hemoglobin content quantification 
Hemoglobin content in mature erythroblast cultures was quantified by Drabkin’s 
assay as described (Campbell et al., 2013). Culture pellets were imaged in 1.1 mL FACS 
tubes (VWR) with an iPhone 4. 
 
N. Immunoprecipitation assays 
For all immunoprecipitation (IP) experiments, cells were lysed in buffer containing 10 
mM Tris (pH 7.4), 150 mM sodium chloride, 0.5% NP-40 (Sigma), 1 mM EDTA (pH 8.0), 
10 µM proteasome inhibitor (MG132, Enzo), and 1:500 protease inhibitor cocktail 
(Sigma). For FLAG- PS immunoprecipitation, 400 million FACS-purified GFP+ G1E cells, 
cultured as described (Weiss et al., 1997), were lysed, precleared with a 1:1 mix of 
Protein A and rProtein G agarose (Invitrogen), and incubated overnight with EZView Red 
Anti-Flag M2 Affinity Gel (Sigma) at 4 oC. After washing thrice with IP buffer, 
immunoprecipitated material was eluted off of beads with 100 µg/mL 3X FLAG peptide 
(Sigma) at 4 °C for 1 hr with intermittent agitation and used for further analyses. 
For DIC immunoprecipitation, precleared lysate from 15 freshly isolated whole E14.5 
murine fetal livers (~300 million cells) were incubated with anti-DIC antibody (Millipore 
MAB #1618) overnight. rProtein G agarose beads (Invitrogen) were then added for 4 hrs 
	  	  	  
46 
at 4 °C. Beads containing immunoprecipitated material were washed thrice in IP buffer, 
boiled in 2X Laemmli Sample Buffer (Sigma), and analyzed immediately.   
 
O. Mass spectrometry 
Immunoprecipitates were size-fractionated by SDS-PAGE (4-15% gradient gel, 
BioRad) and stained with Coomassie Blue Silver overnight. Following washing in 
deionized water, the indicated bands were manually extracted, digested with trypsin, and 
subjected to liquid chromatography and nanospray/linear trap quadrupole mass 
spectrometry using a ThermoFinnigan LTQ linear ion trap mass spectrometer at the 
University of Pennsylvania Proteomics Core Facility. Data were analyzed via Sequest 
and Scaffold3 software packages. Presented data represent unweighted spectral counts, 
unique peptide counts, and percent protein coverage for proteins identified by ≥2 
peptides with >99% protein/>95% peptide confidence. 
 
P. In vitro GST pull down assays 
For the in vitro binding experiments shown in Figures 3.10A and 3.10B, GST and 
GST-PS proteins were prepared in previously described conditions (Kihm et al., 2002). 
E. coli BL21 cells were grown at 37 °C for 3 hrs and induced to express protein by 
addition of 0.1 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) for 3 hrs at 30 °C. Cell 
pellets were resuspended in BC500 buffer (10 mM Tris-HCl (pH 8.0), 500 mM KCl, 20% 
glycerol, 1% NP-40, 0.5 mM EDTA, 1 mM DTT, 0.5 mg/mL lysozyme, 0.05 mg/mL 
DNAse I, and protease inhibitor cocktail (Sigma)) and sonicated. Lysates were clarified 
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by centrifugation at 10,000 rpm for 10 min at 4 °C. Cleared lysates were incubated with 
washed glutathione-Sepharose beads (GE Health Sciences) overnight at 4 °C, washed 
thrice in BC500, and eluted off of beads with 20 mM reduced glutathione solution 
containing 50 mM Tris-HCl (pH 8.8), 100 mM NaCl, 1 mM DTT, and protease inhibitor 
cocktail (Sigma).   
Bovine brain holodynein was purified as described (Bingham et al., 1998). pCMV-
based HA-tagged portions of rat dynein intermediate chain were introduced into 293T 
cells by calcium phosphate transfection. Transfected 293T cells expressing HA-tagged 
DIC constructs were lysed in pull down (PD) Buffer (20 mM Tris pH 7.4, 150 mM 
potassium chloride, 1 mg/mL BSA, 1:500 protease inhibitor cocktail (Sigma)) 24 hrs after 
transfection.  
For pull down assays, recombinant GST or GST-PS (1 µmol at 4 mM final 
concentration) was incubated with substrate (5 µg holodynein (~4 fmol at 16 nM final 
concentration) or 400 µg 293T lysate containing DIC truncation) and 20 µL glutathione-
Sepharose beads (GE Healthcare) in PD Buffer for 2 hrs at 4 °C with rotation. All pipette 
tips and Eppendorf tubes were passivized with 1 mg/mL bovine serum albumin (Sigma) 
prior to use. Beads were subsequently pelleted, washed thrice with PD Buffer, boiled in 
2X Laemmli Sample Buffer (Sigma), and analyzed. 
 
Q. SEC-MALLS experiments  
Our collaborators, Drs. Joel Mackay and Ana Silva, of the School of Molecular 
Bioscience at the University of Sydney, Australia, conducted these experiments. Trim58 
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PS (residues 281-485) and dynein intermediate chain (residues 1-120) were expressed 
separately in E. coli Rosetta 2 (DE3) cells at 25 °C for 16 hrs. Cell pellets were 
resuspended in 50 mM sodium phosphate (pH 7.5) and 0.5 M sodium chloride for GST-
PS, or 50 mM CHES pH 10 and 1 M sodium chloride for GST-DIC(1-120). Cells were 
lysed by sonication following the addition of 1 mg/mL lysozyme, 1 mM DTT, 1 mM 
PMSF, 0.05 mg/mL DNAse I, 0.05 mg/mL RNAse A and Complete EDTA-free protease 
inhibitors (Roche). Cell lysates were incubated with glutathione-Sepharose resin 
(Novagen) for 1 hr at 4 °C and washed. GST-DIC(1-120) was eluted using 30 mM 
glutathione, whereas PS was cleaved from the GST tag with HRV-3C protease overnight 
at 4 °C. Both proteins were then purified by size exclusion chromatography, using a 
Superdex 75 HiLoad 16/600 column. PS was eluted in 20 mM sodium phosphate (pH 
7.5) and 50 mM sodium chloride, and GST-DIC(1-120) in 20 mM CHES pH 10 and 100 
mM sodium chloride.  
Purified PS (200 µL at 3.3 µM) and GST-DIC(1-120) (200 µL at 16.4 µM) were run 
separately on a Superdex 200 10/300 GL column connected to a MiniDawn Treos 
(Wyatt Technology). A mixture of PS and GST-DIC (200 µL of a mixture of PS at 13.2 
µM and GST-DIC at 16.4 µM) was incubated for 1 hr at room temperature and then 
eluted on the same SEC-MALLS setup. All samples were eluted in 20 mM Tris pH 8 and 
100 mM sodium chloride at 0.5 mL/min. Molecular masses were calculated using a 
dn/dc value of 0.185 mL/g. 
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R. Immunofluorescence assay sample preparation 
HeLa cells were transiently transfected on 12 mm coverslips (VWR) with pK1-based 
Trim58 constructs or pEGFP-based mCherry-CC1 (human), using Lipofectamine 2000 
reagent (Invitrogen) per the manufacturer’s instructions. After 36 hrs, cells were fixed in 
4% paraformaldehyde for 5 min, permeabilized in 0.1% Triton-X 100 for 5 min, and 
blocked in PBS containing 3% FBS for 1 hr at room temperature. Transfected HeLa cells 
were stained with GM130 (BD Biosciences) overnight at 4 °C, and then with goat anti-
mouse Alexa Fluor 488 (Invitrogen) for 1 hr at room temperature. Cells were mounted on 
glass slides with Prolong Gold Antifade Reagent with DAPI (Invitrogen).  
For erythroblast immunofluorescence assays, cells were layered onto glass slides 
previously treated with Vectabond reagent (Vector Laboratories) and incubated for 10 
min at 37 °C. Erythroblasts were fixed and permeabilized as described above, stained 
with Alexa Fluor 488-conjugated anti-αTubulin (Millipore) overnight at 4 °C, and 
mounted. 
 
S. Time lapse imaging set up 
HeLa cell lines were plated on a FluoroDish (World Precision Instruments, 0.17 mm-
thick glass bottom) in DMEM (Gibco) containing 10% FBS and 1% sodium pyruvate at a 
concentration of 250,000-500,000 cells per mL. Beginning 24-36 hrs later, cells were 
imaged at 5 min intervals for 12 hrs in an environmental chamber at 37 °C and 5% 
carbon dioxide. 
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T. Microscopy and image analysis 
Time lapse and static erythroblast imaging were performed on an Olympus IX70 
inverted microscope with a Photometrics CoolSnap HQ high-resolution CCD camera. 
Images were acquired and processed using Deltavision Softworx software. Static HeLa 
cell imaging was performed on a Zeiss LSM 710 Confocal microscope with ZEN 2011 
acquisition software. The University of Pennsylvania Perelman School of Medicine Cell 
and Developmental Biology Microscopy Core maintained these microscopes. Images 
were analyzed using FIJI (Schindelin et al., 2012) and Volocity Software (PerkinElmer). 
 
U. Imaging flow cytometry 
For ImageStream analysis, erythroid cultures were fixed in 4% paraformaldehyde for 
15 min at room temperature, washed in PBS, stained with Draq5 (Abcam), and analyzed 
on an Amnis ImageStream Mark II instrument at 40x magnification. GFP+ cells were 
gated using IDEAS software (Amnis) and comprised the base population for morphologic 
analysis based on aspect ratio and Δ centroid values. “Spherical” and “Oblong” cell 
gates were set by manual inspection of fluorescent cell images. A MATLAB program 
was used to identify nucleated cells within the spherical cell population by excluding 
anucleate reticulocytes (Draq5-negative) and multinucleated cells (detected by multiple 
Draq5-positive regions). The efficacy of this program was validated by manual 
inspection. Nuclear diameter, measured by Draq5 diameter, was quantified in MATLAB. 
IDEAS software was used to calculate Δ centroid values within the Draq5-positive, 
spherical cell population for nuclear polarization assessment. For some experiments, 16 
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µM nocodazole (Sigma) was added directly to culture media for the indicated amount of 
time. 
 
V. Mouse work 
Animal protocols were approved by the Institutional Animal Care and Use Committee 
of The Children’s Hospital of Philadelphia (Philadelphia, PA). 
 
W. Statistics 
Statistical analysis was performed using GraphPad Prism 6.0 software (GraphPad 
Software). All multigroup comparisons were done using one-way ANOVA analysis. 
Comparisons between two groups were done using Student’s t-test. Significance was 
set at p<0.05.	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CHAPTER 3:  
THE ROLE OF TRIM58 IN ERYTHROPOIESIS 
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Chapter Summary 
TRIM58 is an E3 ubiquitin ligase superfamily member implicated by genome 
wide association studies (GWAS) to regulate human erythrocyte traits. Here we show 
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that Trim58 expression is induced during late erythropoiesis. Trim58 depletion in primary 
murine erythroid precursors inhibits their maturation from late stage nucleated 
erythroblasts to anucleate reticulocytes. Specifically, imaging flow cytometry studies 
demonstrate that Trim58 regulates polarization and/or extrusion of erythroblast nuclei. 
Protein interaction studies demonstrate that Trim58 binds directly to the intermediate 
chain of the microtubule motor dynein and induces degradation of the dynein complex. 
During erythropoiesis, Trim58 expression, dynein loss and enucleation occur 
concomitantly and all are inhibited by Trim58 shRNAs. Dynein regulates nuclear 
positioning and microtubule organization, both of which undergo changes during 
erythroblast enucleation. Thus, we propose that Trim58 regulates this process by 
eliminating dynein. Our findings identify the first erythroid-specific regulator of 
enucleation and elucidate a previously unrecognized mechanism for controlling dynein 
activity. 
Figures and Tables can be found at the end of the text.	  
	  
Introduction 
Humans produce about 2 million red blood cells each second to replace those 
lost by senescence (McGrath and Palis, 2008) in a process termed erythropoiesis. 
Mature red blood cells (erythrocytes) contain high levels of the O2 carrier hemoglobin and 
are distensible enough to withstand repeated passages through narrow capillary beds. 
These properties are acquired during precursor maturation through specialized cell 
divisions associated with activation of erythroid specific genes (Cheng et al., 2009; 
Welch et al., 2004), repression of alternate lineage genes (Cheng et al., 2009; Kingsley 
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et al., 2013; Welch et al., 2004), global DNA demethylation (Shearstone et al., 2011), 
reduced cell volume (Dolznig et al., 1995) and ejection of the nucleus to yield a 
reticulocyte, which develops further into a mature red blood cell (Liu et al., 2010). The 
mechanisms that govern these changes in cell structure and morphology are 
incompletely understood.  
The process of nuclear expulsion from erythroblasts (Keerthivasan et al., 2011; 
Konstantinidis et al., 2012b) occurs exclusively in mammals and may represent an 
evolutionary adaptation to optimize erythrocyte rheology for transport through small 
capillary beds (Gaehtgens et al., 1981a; Mueller et al., 2008). Erythroblast enucleation is 
preceded by nuclear condensation and requires histone deacetylation (Ji et al., 2010; 
Popova et al., 2009) and suppression of the Myc proto-oncogene (Jayapal et al., 2010). 
The condensed nucleus polarizes to one side of the cell via transport mechanisms that 
require microtubules and phosphoinositide 3-kinase (Wang et al., 2012), followed by Rac 
GTPase-mediated formation of a contractile actomyosin ring between the incipient 
reticulocyte and nucleus (Ji et al., 2008; Konstantinidis et al., 2012b). Forces generated 
by the contractile ring promote further nuclear extrusion (Ji et al., 2008; Wang et al., 
2012). Final separation between the reticulocyte and nucleus is facilitated by transport of 
lipid vesicles to the interface, which facilitates remodeling and resolution of the plasma 
membrane surrounding both structures (Keerthivasan et al., 2010; Keerthivasan et al., 
2011). The ejected nucleus with surrounding plasma membrane is termed a pyrenocyte 
(McGrath et al., 2008). In vivo, free pyrenocytes are scavenged by macrophages (Soni 
et al., 2006), while reticulocytes are released into the circulation and undergo further 
maturation (Gifford et al., 2006). This process shares several features with cytokinesis 
(Keerthivasan et al., 2010; Konstantinidis et al., 2012b). Moreover, all of the proteins 
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currently known to participate in erythroblast enucleation are ubiquitously expressed and 
most function in mitosis. How erythroblasts co-opt generalized mitotic machinery for the 
lineage specific process of enucleation is unknown. Presumably, this is mediated in part 
by the expression of one or more erythroid restricted proteins. 
Here, we identify a role for the erythroid protein Trim58 in erythroblast 
enucleation. Trim58 is a member of the tripartite motif-containing family of proteins, 
whose members function as E3 ubiquitin ligases broadly in physiology and disease 
(Napolitano and Meroni, 2012). Genome-wide association studies (GWAS) show that 
single nucleotide polymorphisms (SNPs) linked to the human TRIM58 gene associate 
with variations in the size and/or number of circulating erythrocytes (Kamatani et al., 
2010; van der Harst et al., 2012). Here we identify Trim58 as an erythroid restricted 
protein that facilitates erythroblast enucleation. Mechanistic studies suggest that Trim58 
exerts this function by inducing degradation of the microtubule motor dynein. These 
findings are the first to identify an erythroid specific protein that participates in 
erythroblast enucleation, likely by targeting a ubiquitous protein complex that is essential 
for normal function in virtually all other eukaryotic cells.  
 
Results 
 
Trim58 is induced during late stage erythropoiesis 
High-level human TRIM58 expression is specific to the erythroid lineage (Figures 
3.1A and 3.1B) and is strongly induced during the late stages of maturation (Figure 
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3.1C). In situ hybridization analysis of embryonic day 14.5 (E14.5) mouse embryos 
showed predominant Trim58 mRNA expression in the fetal liver, an erythropoietic tissue 
(Figure 3.2A). Semiquantitative real-time PCR showed that Trim58 mRNA is upregulated 
>100-fold in late stage murine fetal liver erythroid precursors (Figure 3.2B). Chromatin 
immunoprecipitation-sequencing (ChIP-Seq) of primary erythroblasts demonstrated that 
the essential erythroid transcription factors Gata1 and SCL/Tal1 bind the Trim58 locus 
within the first intron, a common location for erythroid specific enhancers (Figure 3.2C) 
((Cheng et al., 2009) and Pimkin et al, in revision). Thus, the Trim58 gene is strongly 
and specifically induced during terminal erythroid maturation, in part via direct activation 
by key hematopoietic transcription factors. 
 
Trim58 regulates erythroblast enucleation 
We used shRNAs to suppress Trim58 expression during the in vitro maturation of 
primary fetal liver erythroblasts (Zhang et al., 2003). We infected purified E14.5 murine 
fetal liver erythroid precursors with retroviruses encoding Trim58-directed or control 
shRNAs along with a puromycin resistance cassette and green fluorescent protein 
(GFP) (Figure 3.3A) (Hemann et al., 2003). Infected cells were cultured for 1-3 days with 
dexamethasone, stem cell factor (SCF), erythropoietin (Epo) and puromycin to promote 
immature erythroblast expansion and select for infected cells. The erythroblasts were 
then switched to medium containing Epo only, which induced maturation to the 
reticulocyte stage. Four different shRNAs reduced Trim58 mRNA and protein by 60-90% 
(Figures 3.3B and 3.3C). During late erythroid maturation, erythroblasts expel their 
nuclei to become anucleate reticulocytes that are Hoechst-negative by flow cytometry 
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(Figure 3.4A). The kinetics of enucleation were delayed in Trim58-deficient cultures 
(Figure 3.4B), and enucleation was consistently inhibited at 48 hrs maturation by all four 
Trim58-directed shRNAs analyzed compared to controls (Figures 3.4C). Histological 
staining confirmed these findings, showing reduced proportions of reticulocytes in 
Trim58-deficient cultures (Figures 3.4D and 3.4E). Trim58 suppression also increased 
the proportions of mature erythroblasts containing two or more nuclei (Figure 3.5). 
Several parameters of erythroid maturation were not altered by Trim58 
knockdown, including downregulation of the cell surface marker CD44 (Figure 3.6) 
(Chen et al., 2009). Trim58 knockdown produced only small and inconsistent effects on 
erythroblast proliferation (Figure 3.7A) and viability (Figure 3.7B). Hemoglobin 
accumulation (Figure 3.8A) and nuclear condensation (Figure 3.8B) occurred normally 
after Trim58 knockdown. Overall, these findings demonstrate that Trim58 depletion 
caused selective defects during late stage erythropoiesis, including reduced enucleation 
and also increased formation of multinucleated cells.  
 
Trim58 binds the molecular motor dynein 
Trim58 is predicted to be an E3 ubiquitin ligase with characteristic functional 
modules, including a PRY-SPRY (PS) domain that mediates substrate interactions 
(Figure 3.9A) (James et al., 2007; Woo et al., 2006b). We performed pull down studies 
to identify Trim58 protein-binding partners, including potential degradation substrates. 
We used the isolated PS domain for these studies because ectopic expression of full-
length wild type (WT) Trim58 was toxic to erythroblasts (data not shown). We expressed 
FLAG epitope-tagged PS domain in the erythroblast cell line G1E (Weiss et al., 1997), 
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which contains no endogenous Trim58 protein, immunoprecipitated (IP) with FLAG 
antibody and analyzed the recovered proteins by SDS-polyacrylamide gel 
electrophoresis. This analysis identified five discrete protein bands (Figure 3.9B). Mass 
spectrometry of these bands identified multiple subunits of the cytoplasmic microtubule 
motor protein complex dynein (Table 3.1), as well as nuclear pore complex proteins, a 
Golgi component, and several other proteins (Table 3.2). Dynein regulates nuclear 
positioning and microtubule structure within cells (McKenney et al., 2010; Splinter et al., 
2010) and it was already known that erythroblast enucleation is microtubule-dependent 
(Konstantinidis et al., 2012b; Wang et al., 2012). Therefore, to investigate further a 
potential role for Trim58 in erythroblast enucleation, we focused on its interactions with 
dynein.  
We confirmed the Trim58-dynein interaction in G1E cells by FLAG-IP followed by 
Western blotting for dynein intermediate chain (DIC) and dynein heavy chain (DHC) 
(Figure 3.9C). Immunoprecipitation of DIC from mouse fetal liver recovered Trim58, 
demonstrating an interaction between the endogenous proteins (Figure 3.9D). In vitro 
pull down assays showed that recombinant GST-tagged PS interacted with purified 
holodynein, indicating a direct and specific interaction (Figure 3.10A). Dynein is a multi-
subunit complex that includes DHC, DIC, light intermediate chains, and light chains. The 
DIC mediates dynein interactions with several accessory proteins, mainly via the amino 
terminus (McKenney et al., 2011; Vallee et al., 2012). To test whether Trim58 interacted 
with DIC, we expressed hemagglutinin (HA)-tagged segments of the DIC amino terminus 
in 293T cells, incubated lysates with GST proteins and glutathione-Sepharose beads, 
and analyzed interacting polypeptides (Figure 3.10B). Western blotting for HA showed 
that PS interacted with DIC through an interface within the first 73 amino acids. We then 
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used size-exclusion chromatography coupled to multiangle laser light scattering (SEC-
MALLS) to confirm this interaction in vitro using purified PS and DIC (residues 1-120). 
Bacterially expressed PS and GST-DIC(1-120) each eluted in gel filtration as a single 
peak when run individually (Figure 3.10C). MALLS data, which provide a reference-free 
estimate of solution molecular weight, showed that PS eluted as a monomer (observed 
MW = 25.6 kD; expected mass = 23.3 kD), whereas GST-DIC(1-120) ran as a dimer 
(observed MW = 91.2 kD; expected mass of dimer = 79.6 kD), as a result of the known 
dimerization of GST (Fabrini et al., 2009). A ~1:1 mixture of the two proteins also eluted 
predominantly as a single peak with a lower retention time, as expected for the formation 
of a complex. The molecular weight of this signal calculated from MALLS data (126.2 
kD) is consistent with a 2:2 complex (expected mass = 114.4 kD) that represented a 1:1 
Trim58-DIC complex that additionally dimerized through the GST moiety. Together, 
these data show that Trim58 binds dynein directly through physical interactions between 
its PS domain and the DIC amino-terminus (Figure 3.10D). This region of DIC contains a 
coiled coil domain that interacts with other dynein regulatory proteins, including the 
dynactin subunit p150Glued and NudE (Ma et al., 1999; McKenney et al., 2011). 
 
Trim58 promotes dynein degradation 
 Next, we expressed FLAG/mCherry-tagged full length WT Trim58 in HeLa cells, 
which do not express endogenous Trim58, and assessed the effects on dynein protein 
levels. As controls, we expressed vector alone (V) or a “RING-dead” (RΔ) Trim58 
containing two missense mutations predicted to abrogate E3 ligase activity (Figure 
3.11A) (Zhang et al., 2012a). The cultures were treated with puromycin for 3 days to 
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enrich for infected cells and analyzed by Western blotting (Figure 3.11B). Although WT 
Trim58 slowed cell proliferation, we were able to create viable, stably expressing lines. 
Compared to the RΔ mutant, WT Trim58 was poorly expressed, likely due its 
autoubiquitylation and subsequent proteasomal degradation, which occur with other Trim 
proteins (Versteeg et al., 2013). Dynein subunits DHC and DIC were nearly absent from 
cells expressing WT Trim58, but not from cells expressing the RΔ version or the vector 
alone (Figure 3.11B and data not shown). In order to assess the mechanism through 
which Trim58 expression causes dynein loss, Trim58-expressing HeLa cells were 
treated with the proteasome inhibitor MG132. As shown in the right-hand panel of Figure 
3.11B, MG132 increased the expression of dynein and WT Trim58. Thus, Trim58 
promotes the degradation of itself and of dynein via mechanisms that require E3 
ubiquitin ligase activity and proteasomes.  
We then investigated whether Trim58 expression elicited cellular phenotypes 
characteristic of dynein loss. Dynein transports Golgi bodies along microtubules into 
perinuclear stacks at the microtubule organizing center (MTOC) (Quintyne et al., 1999). 
Inhibition of dynein by overexpression of CC1, a portion of p150Glued that interferes with 
the DIC-dynactin interaction, causes Golgi fragmentation and dispersal throughout the 
cytoplasm (Quintyne et al., 1999). We verified this result in HeLa cells and showed that 
WT Trim58, but not the RΔ mutant, produced a similar effect (Figure 3.12). Dynein also 
functions in mitotic spindle checkpoint inactivation to facilitate anaphase onset (Howell et 
al., 2001). Ectopic expression of WT Trim58 in HeLa cells caused mitotic defects 
characteristic of dynein inhibition, including prolonged interval between cell rounding and 
anaphase (Figures 3.13A and 3.13B) and cell death after rounding (Figure 3.13B right 
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panel) that were significantly worse than cells expressing vector or RΔ Trim58. Thus, 
ectopic expression of Trim58 in heterologous cells induces phenotypes that are 
consistent with dynein deficiency.  
 
Trim58 expression in erythroblasts coincides with loss of dynein and enucleation 
We investigated whether endogenous Trim58 expression promotes dynein loss 
during erythropoiesis. In murine erythroblast cultures undergoing semi-synchronous 
maturation, the induction of Trim58 protein at 24 hours correlated with loss of dynein 
subunits (DIC and DHC, Figure 3.14A) and the onset of enucleation (Figure 3.14C, black 
bars). The absence of dynein in late stages of erythroid maturation is consistent with 
proteomic studies of murine (Pasini et al., 2008) and human (Goodman et al., 2007) 
erythrocytes. In contrast, Trim58-deficient cells retained dynein protein aberrantly 
(Figures 3.14B and 3.15) and enucleation was delayed (Figures 3.14C gray bars). 
Dynein expression still declined in Trim58 knockdown erythroblasts, but with a ~12 hr 
delay. The eventual degradation of most dynein by 44 hours may be due to incomplete 
suppression of Trim58 and/or alternate protein degradation mechanisms. Overall, our 
findings demonstrate that expression of Trim58 destabilizes dynein and promotes 
enucleation. These findings are consistent with a model in which Trim58-mediated 
degradation of dynein and erythroblast enucleation are mechanistically linked.  
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Trim58 regulates nuclear polarization 
We used the Amnis ImageStream, which combines flow cytometry with 
fluorescent microscopy, to compare specific steps of enucleation in Trim58-depleted and 
control erythroid cultures undergoing semi-synchronous maturation (see Figures 3.3, 
3.4, and 3.14) (Konstantinidis et al., 2012b). Erythroblasts infected with shRNA 
retroviruses were identified by GFP expression, and nuclei were stained with the cell 
permeable DNA dye Draq5. We first measured changes in nuclear diameter as a 
function of time to assess nuclear condensation during maturation (Figures 3.16A-C and 
3.17A). Overall, no significant differences in condensation were observed between 
control and Trim58-depleted cells (Figure 3.17A), in agreement with findings obtained by 
microscopic analysis of cytocentrifuged cells (Figure 3.8B). We next measured the 
aspect ratio (minor/major axis) and Δ centroid (distance between centers of the nucleus 
and cytoplasm) to distinguish spherical nucleated cells from oblong ones that were 
extruding their nuclei (Figures 3.16A-C). Spherical cells accumulated in Trim58-depleted 
cultures (Figure 3.17B), while the production of oblong cells undergoing nuclear 
extrusion was delayed (Figure 3.17C). Thus, Trim58 facilitates enucleation after the step 
of nuclear condensation.  
We next assessed whether Trim58 regulated nuclear positioning specifically 
within the population of spherical cells depicted in Figure 3.17B, by measuring their Δ 
centroid distribution (Figures 3.18A and 3.18B). At 32 and 36 hours maturation, the 
mean Δ centroid was significantly reduced in Trim58 depleted spherical cells, indicating 
impaired nuclear polarization. Treatment of control erythroblasts with nocodazole 
produced similar, albeit stronger effects (Figure 3.19), consistent with previous studies 
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(Konstantinidis et al., 2012b; Wang et al., 2012). Thus, erythroblast nuclear polarization 
is Trim58- and microtubule-dependent.  
We then used immunofluorescence to examine relationships between 
microtubule structure and nuclear positioning during enucleation. Erythroblast nuclei are 
surrounded by a network or “cage” of microtubules, similar to what occurs in most cells 
(Figure 3.20i) (Tsai et al., 2010; Wilson and Holzbaur, 2012). During enucleation, the 
nucleus moves away from the MTOC (Figure 3.20 and (Konstantinidis et al., 2012b; 
Wang et al., 2012)), opposite to what would occur with minus end-directed dynein 
transport. Later, the microtubule cage partially collapses, becoming detached from the 
cell cortex and nucleus as the latter is extruded (Figures 3.20ii-iv). Dynein stabilizes 
microtubules and tethers them to the cell cortex (Hendricks et al., 2012). Thus, events 
observed during enucleation, including directional nuclear movement and microtubule 
cage collapse (Figure 3.21), may be facilitated by dynein loss (see Figure 3.14). 
 
Discussion 
Genome wide association studies suggest that the E3 ubiquitin ligase 
superfamily member TRIM58 regulates human erythrocyte traits, including cell size and 
number (Kamatani et al., 2010; van der Harst et al., 2012). Here we support further a 
role for Trim58 in erythropoiesis and provide insight into the associated mechanisms. 
Trim58 binds dynein directly through its intermediate chain subunit and promotes 
proteasomal degradation of the holocomplex. During erythropoiesis, Trim58 expression 
correlates with dynein loss and enucleation. Both of these processes are inhibited by 
Trim58 depletion. Thus, we propose that Trim58 mediates erythroblast enucleation by 
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interfering with the established ability of dynein to regulate nuclear positioning and/or 
microtubule structure within cells (Figure 3.21) (McKenney et al., 2010; Splinter et al., 
2010; Tanenbaum et al., 2011; Tsai et al., 2010; Wilson and Holzbaur, 2012). Our 
findings provide functional correlates for GWAS findings and identify a lineage-specific 
protein that alters the ubiquitous process of microtubule motor dynamics to regulate the 
highly specialized process of erythroblast enucleation. 
According to our model (Figure 3.21), delayed enucleation caused by Trim58 
deficiency should be alleviated by inhibiting dynein through alternate mechanisms. 
However, our attempts to inhibit dynein in wild type and Trim58-deficient erythroblasts 
using dynein intermediate chain-directed shRNAs, dynein heavy chain-directed shRNAs, 
overexpressed CC1 (Quintyne et al., 1999) or the chemical inhibitor ciliobrevin 
(Firestone et al., 2012) caused cell death in maturing erythroblasts prior to enucleation 
(data not shown), which undermined our ability to discern whether these treatments 
augmented enucleation. Similarly, retroviral expression of Trim58 in erythroblasts prior to 
their enucleation was toxic. These findings indicate that the physiological timing and 
magnitude of Trim58 expression and consequent dynein degradation must be exquisitely 
regulated to occur exclusively in post-mitotic erythroblasts during enucleation, in order to 
preserve dynein-dependent processes required for earlier stages of cellular maturation.  
In most cells, networks or “cages” of microtubules surround the nucleus and 
regulate its spatial orientation through the actions of directionally opposed dynein and 
kinesin motors (Wilson and Holzbaur, 2012). During erythroblast enucleation, the 
nucleus moves away from the MTOC (Konstantinidis et al., 2012b; Wang et al., 2012) 
and is ultimately released from the encompassing microtubule cage (Figure 3.20). By 
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degrading dynein, Trim58 could facilitate these processes via two potential mechanisms 
(Figure 3.21). On one hand, movement of the nucleus during enucleation is directionally 
opposed to the minus end-directed motor actions of dynein. Thus, Trim58-mediated 
suppression of dynein may create a “microtubule motor imbalance”, allowing the plus 
end-directed actions of kinesins to polarize the nucleus away from the MTOC. 
Alternatively, dynein normally stabilizes microtubules and mediates their attachment to 
the cell cortex (see (Hendricks et al., 2012) and references therein). Thus, Trim58-
mediated dynein degradation in late stage erythroblasts may destabilize microtubules, 
promoting their detachment from both the cell cortex and nuclear membrane (i.e., 
“microtubule cage collapse”) thereby facilitating nuclear movement and release. Of note, 
dynein loss and enucleation are significantly delayed, but not eliminated by Trim58 
shRNAs (see Figure 3.14). This may be explained by incomplete suppression of Trim58. 
Alternatively, redundant systems, including other ubiquitin ligases, autophagy, and/or 
proteases, may cooperate with Trim58 to degrade dynein during late stage 
erythropoiesis. We favor the latter possibility, which is consistent with the extensive 
repertoire of proteolytic systems present in late stage erythroblasts (Khandros and 
Weiss, 2010). 
Kinesin-1 regulates nuclear movement in numerous cell types (Tanenbaum et al., 
2011) and its Kif5b isoform is abundant in murine (Kingsley et al., 2013) and human 
(Merryweather-Clarke et al., 2011) erythroblasts. However, shRNA-mediated knockdown 
of Kif5b did not antagonize the deleterious effects of Trim58 deficiency on enucleation’ 
as would be predicted by the “microtubule motor imbalance” model (Figure 3.22). This 
finding supports the alternative mechanism of “microtubule cage collapse”. However, at 
least 10 additional kinesin family members are expressed during erythropoiesis 
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((Kingsley et al., 2013; Merryweather-Clarke et al., 2011) and Figure 3.22), making it 
difficult to draw a definitive conclusion from the Kif5b knockdown data. Systematic 
inhibition of these kinesin genes, either separately or in combinations, may determine 
whether any participate in nuclear polarization during erythroblast enucleation.  
Several lines of evidence suggest important roles for proteasome-mediated 
protein degradation during erythroblast maturation (Khandros and Weiss, 2010) and 
enucleation (Chen et al., 2002)., but only a few specific pathways are currently defined. 
For example, the ubiquitin ligases Mdm2 and Mdm4 foster erythropoiesis by inhibiting 
p53 (Maetens et al., 2007) and the ubiquitin ligase Cul4A regulates erythropoiesis by 
targeting the cell cycle inhibitor p27 (Li et al., 2006). To our knowledge, Trim58 
represents the first lineage-specific ubiquitin ligase shown to be involved in erythroid 
maturation and in particular the enucleation step. There are two likely mechanisms by 
which Trim58 might mediate degradation of bound dynein. First, Trim58 might promote 
the transfer of K48-linked polyubiquitin onto DIC and/or other subunits, targeting dynein 
to the proteasome. Alternatively, Trim58 might autoubiquitylate, stimulating its own 
proteasomal targeting along with that of bound dynein, similar to the mechanism by 
which the related protein Trim21 mediates degradation of IgG-bound intracellular virions 
(Mallery et al., 2010).  
It is also possible that Trim58 promotes erythroid maturation via dynein-
independent mechanisms through interactions with other binding partners, including 
those identified by our IP studies (Table 3.2). For example, Trim58 binds several nuclear 
pore complex proteins, including Nup153 and Nup50. These proteins function in mitosis 
(Chatel and Fahrenkrog, 2011; Mackay et al., 2009), a process that shares some 
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features with enucleation (Keerthivasan et al., 2011). Like dynein, Nup153 is 
downregulated during erythropoiesis, but the latter process does not appear to be 
dependent on Trim58 (Figures 3.14A and 3.14B). However, some Trim family members 
function through proteasome-independent mechanisms, for example by catalyzing 
SUMOylation of substrates (Chu and Yang, 2011; Napolitano and Meroni, 2012); this 
may also be the case for Trim58 interactions with Nup153/50 and/or other proteins.  
Genome wide association studies offer a population-based approach to identify 
genes that regulate health-related traits. However, GWAS typically identify single 
nucleotide polymorphisms within linkage disequilibrium blocks that contain multiple 
genes, and it can be challenging to identify the specific gene(s) that influence the trait of 
interest (Hindorff et al., 2009; Peters and Musunuru, 2012). Moreover, alleles discovered 
by GWAS usually cause subtle alterations in gene expression or function, providing a 
minimal estimate of the role of a particular gene in the biological process of interest 
(Sankaran and Orkin, 2013). Our gain- and loss-of-function studies address these 
general issues by demonstrating a specific role for Trim58 in erythroid cells and by 
identifying a relevant molecular pathway. Of note, GWAS also identify TRIM58 as a 
candidate gene for regulating human platelet numbers (Gieger et al., 2011). Consistent 
with this observation, Trim58 expression is induced in megakaryocytes, likely via Gata1 
and SCL/Tal1 (Figure 3.23), similar to what we observed in erythroid cells. These 
observations are interesting in light of findings that dynein promotes platelet production 
by regulating microtubule dynamics in megakaryocytes (Patel et al., 2005). Thus, Trim58 
might regulate platelet formation through its interactions with dynein. Overall, our 
findings illustrate how mechanism-based investigations can synergize with GWAS to 
elucidate new biological pathways. 
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Dynein is expressed ubiquitously in eukaryotes and performs a wide array of 
functions. Consequently, considerable efforts have been directed toward understanding 
how dynein activities are regulated during cellular development, cell cycle progression, 
and in different lineages. Dynein cargo preference and motor activity are modulated 
largely by protein interactions and perhaps by post-translational modifications (Vallee et 
al., 2012). Our findings demonstrate that dynein is also regulated by precisely timed, 
lineage-specific degradation. It will be interesting to explore the generality of this finding 
by investigating whether dynein stability is regulated in non-erythroid tissues through 
interactions with Trim58 or other ubiquitin ligases. 
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Tables 
 
Table 3.1. Dynein subunits identified by mass spectrometric analysis of proteins 
that coimmunoprecipitated with the Trim58 PRY-SPRY domain in erythroid cells. 
The bands in Figure 3.9B that contained each protein are noted. MW, molecular weight.  
Protein Name Accession MW Band Unweighted 
Spectra 
Unique 
Peptides 
Percent 
Coverage 
Cytoplasmic dynein 1       
Heavy chain 1 IPI00119876 532 kD 1 189 95 19 
Intermediate chain 2 IPI00131086 68 kD 3 16 7 14 
Light intermediate chain 1 IPI00153421 57 kD 3,4 38 12 27 
Light intermediate chain 2 IPI00420806 54 kD 4 12 7 16 
       
Trim58 PRY-SPRY (Bait)       
Trim58 IPI00353647 55 kD 4,5 91 14 26 
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Table 3.2. Proteins other than dynein subunits that were identified by mass 
spectrometry in FLAG-PS or Vector control IP samples. The bands in Figure 3.9B 
that contained each protein are noted. MW, molecular weight; % Cvg, % coverage. Spc, 
Spectra. Unq Pep, Unique Peptides. 
 
    FLAG-PS  Vector  
Protein Name Accession MW Band Spectra Unique 
Peptides 
% 
Cvg 
 Spc Unq
Pep 
% 
Cvg 
Golgin α3 
 
IPI00336281 163 kD 2 67 28 20     
Nucleoporin 153 
 
IPI00330624 152 kD 2 48 25 18     
Importin α2 
 
IPI00124973 58 kD 3,4 38 9 21     
Nucleoporin 50 
 
IPI00120572 49 kD 4,5 34 13 32     
Ig kappa chain V-II region 
26-10 
 
IPI00464378 12 kD 5 20 5 26  10 3 22 
dehydrogenase/reductase 
SDR family member 4 
isoform 1 
IPI00318750 30 kD 5 17 7 22  10 5 18 
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Ig gamma-1 chain C 
region, membrane-bound 
form 
 
IPI00308213 43 kD 4,5 16 5 14  4 2 6 
Importin β1 
 
IPI00323881 97 kD 3 12 5 6     
Similar to Chain L, 
Structural Basis Of 
Antigen Mimicry In A 
Clinically Relevant 
Melanoma Antigen 
System isoform 1 
 
IPI00406213 26 kD 5 10 5 22  7 4 18 
Isoform 3 of A-kinase 
anchor protein 9 
 
IPI00623749 434 kD 1 9 7 2     
Tubulin beta-2B chain 
 
IPI00109061 50 kD 4 9 5 12     
Isoform 1 of 6-
phosphofructokinase type 
C 
 
IPI00124444 85 kD 2 6 4 4     
Tubulin alpha-1A chain IPI00110753 50 kD 4 6 4 11     
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DNA replication licensing 
factor MCM5 
 
IPI00309398 82 kD 3 5 3 4     
Elongation factor 1-alpha 
2 
 
IPI00119667 50 kD 4 5 2 5     
Splicing factor 4 
 
IPI00454015 73 kD 3 5 3 5     
6-phosphofructokinase, 
muscle type 
 
IPI00331541 85 kD 3 4 3 3     
ATP synthase subunit 
alpha, mitochondrial 
 
IPI00130280 60 kD 4 4 2 4     
Phosphate carrier protein, 
mitochondrial 
 
IPI00124771 40 kD 5 4 2 6     
Serine/threonine-protein 
kinase 38 
 
IPI00126943 54 kD 4 4 3 7     
ADP/ATP translocase 2 
 
IPI00127841 33 kD 5 3 2 6     
cAMP-dependent protein 
kinase type II-beta 
IPI00224570 46 kD 4 3 2 5     
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regulatory subunit 
 
Putative uncharacterized 
protein 
 
IPI00396787 67 kD 4 3 2 3     
Heat shock cognate 71 
kD protein 
 
IPI00323357 71 kD 3 2 2 4     
Isoform 2 of DNA-directed 
RNA polymerase I subunit 
RPA49 
 
IPI00120981 49 kD 4 2 2 4     
Protein LSM14 homolog A 
 
IPI00172202 51 kD 4 2 2 4     
RuvB-like 1 IPI00133985 50 kD 4 2 2 6     
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Figures 	  
Figure 3.1. Human Trim58 expression is restricted to late stage erythroblasts. 
Human TRIM58 mRNA expression levels were measured by microarray analysis in (A) a 
panel of human tissue types (Wu et al., 2009), (B) a panel of human hematopoietic 
tissues (Novershtern et al., 2011), and (C) cultured primary human erythroblasts from 
peripheral blood buffy coat mononucleocytes (Merryweather-Clarke et al., 2011). The 
results in panel C represent mean ± SD for 3 biological replicates normalized to the 
average expression level in CFU-E cells, which were assigned a value of 1. **p<0.01. 
CFU-E, erythroid colony-forming units; Pro-E, proerythroblasts; Int-E, intermediate 
(basophilic) erythroblasts; Late-E, late (orthochromatic) erythroblasts. 
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Figure 3.2. Murine Trim58 is expressed during late stage erythropoiesis. (A) RNA in 
situ hybridization for Trim58 mRNA in a day 14.5 mouse embryo showing strong 
expression (red) in fetal liver, the site of definitive erythropoiesis. (B) Primary murine 
fetal liver erythroblasts were FACS-purified using a previously described gating strategy 
(Pop et al., 2010) and Trim58 mRNA was analyzed by semiquantitative real-time PCR. 
The y-axis shows relative mRNA expression, normalized to S0 cells, which were 
assigned a value of 1. The results represent mean ± SEM for 3 biological replicates. 
*p<0.05. (C) Chromatin immunoprecipitation-sequencing (ChIP-Seq) analysis of 
transcription factor binding to the Trim58 locus in primary murine erythroblasts (data 
from Pimkin et al, in revision). The blue line depicts the Trim58 gene, with exons shown 
as rectangles. Transcription factor binding sites are indicated in red.  
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Figure 3.3. Trim58-directed shRNAs reduce expression in murine erythroblast 
cultures. (A) Embryonic day 14.5 murine fetal liver erythroid precursors were purified, 
infected with retroviruses encoding Trim58 or control shRNAs, and cultured for 24-72 hrs 
in expansion medium with puromycin (Puro) to select for infected cells. The cells were 
then switched to maturation medium, which facilitates development to the reticulocyte 
stage over ~48 hrs. Epo, erythropoietin; SCF, stem cell factor; Dex, dexamethasone. 
Scale bar, 10µm. (B) Western blot for Trim58 in erythroblasts expressing Trim58-
directed or control shRNAs at 48 hrs maturation. Luc, luciferase; Scr, scrambled. The 
asterisk (*) represents a nonspecific band. “Long” and “short” exposures are from the 
same blot. (C) Suppression of Trim58 mRNA expression by four shRNAs. Trim58 mRNA 
levels were measured at 48 hrs maturation by semiquantitative real time PCR and 
normalized to the average expression value for Gapdh, Actin, and Hprt mRNA levels. 
The y-axis represents mRNA expression level compared to the average value for 
control-treated samples (Vector, shLuc, shScr), which was set at 1. Results represent 
mean ± SD for 4 biological replicates. 
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Figure 3.3 
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Figure 3.4. Trim58 knockdown inhibits murine erythroblast enucleation. (A) FACS 
analysis for enucleation of control (shLuc) and Trim58-deficient (shTrim58 #4) erythroid 
cultures at the indicated time points. During maturation, erythroblasts become smaller, 
indicated by decreased forward scatter, and ultimately enucleate to become Hoechst-
negative reticulocytes (boxed regions). (B) Summary of percent (%) enucleation at the 
indicated time points in cultures treated with control (shLuc) or Trim58-directed (#4) 
shRNAs. Results represent mean ± SD for 3 biological replicates. (C) Four Trim58-
directed shRNAs inhibit enucleation. Following 48 hrs maturation, erythroblasts treated 
with the indicated shRNAs were analyzed by FACS for enucleation. (D) Representative 
histologies of control (shLuc) and Trim58-deficient (shTrim58 #4) erythroid cultures after 
36 hrs maturation. Red arrows denote anucleate reticulocytes. Scale bar, 20 µm. R, 
reticulocyte; E, erythroblast; N, extruded nucleus. (E) Summary of cell counts from panel 
D showing percent (%) reticulocytes. Six hundred cells were counted on each slide.
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Figure 3.5. Trim58 knockdown results in multinucleated erythroblasts. Murine fetal 
liver erythroblasts were infected with control retrovirus(es) (empty Vector; shLuc, 
Luciferase; and/or shScr, Scrambled), Trim58-directed shRNA(s) (sh58 #3, #4, #5, 
and/or #7) and/or mock-treated. Infected cells were expanded with puromycin for 72 hrs 
and then induced to mature at time 0. (A) At 48 hrs maturation, erythroblasts treated with 
shTrim58 #4 were cytocentrifuged onto a glass slide, stained with May Grünwald and 
Giemsa reagents, and visualized by light microscopy. Arrows denote binucleate 
erythroblasts (BE). Scale bar, 10 µm. (B) The percentage of cells containing 2 or more 
nuclei was quantified by visual inspection. Results represent mean ± SD for 3 
independent experiments with >200 cells counted per treatment group per experiment.  
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Figure 3.6. Trim58 knockdown does not affect CD44 downregulation kinetics 
during erythroid maturation. Erythroblasts expressing control (shLuc, black) or Trim58 
(sh58 #4, gray) shRNAs were analyzed serially by flow cytometry for CD44, a cell 
surface marker that progressively decreases during erythroid maturation (Chen et al., 
2009). Representative histogram plots of FACS data are shown. Below the histograms 
are line graphs depicting CD44 mean fluorescence intensity (mfi) over time (mean ± SD 
for 4 biological replicates). % max, percent (%) of maximum cell count.  
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Figure 3.7. Trim58 knockdown does not affect cell proliferation or viability. Murine 
fetal liver erythroblasts were infected with control retrovirus(es) (empty Vector; shLuc, 
Luciferase; and/or shScr, Scrambled), Trim58-directed shRNA(s) (sh58 #3, #4, #5, 
and/or #7) and/or mock-treated. Infected cells were expanded with puromycin for 72 hrs 
and then induced to mature at time 0. (A) Infected erythroblast proliferation was 
quantified at 0, 24, and 48 hrs maturation. Cell numbers were normalized to the cell 
count at 0 hrs. Results represent mean ± SD for 4 biological replicates. (B) Cell viability 
was measured by fluorescent amino-reactive (LiveDead) staining at 0, 24, and 48 hrs 
maturation. Results represent mean ± SD for 4 biological replicates. A key depicting the 
color of each treatment group is shown to the right.  
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Figure 3.8. Trim58 knockdown does not affect Hb content or nuclear 
condensation. Murine fetal liver erythroblasts were infected with control retrovirus(es) 
(empty Vector; shLuc, Luciferase; and/or shScr, Scrambled), Trim58-directed shRNA(s) 
(sh58 #3, #4, #5, and/or #7) and/or mock-treated. Infected cells were expanded with 
puromycin for 72 hrs and matured for 48 hours. (A) Hemoglobin content measured at 48 
hrs maturation, normalized to total cellular protein. Results represent mean ± SD for 3 
independent experiments. The top panel shows the red color of cell pellets. (B) Nuclear 
size quantification at 48 hrs maturation. Erythroblasts treated with the indicated shRNAs 
were centrifuged onto a slide and stained with May Grünwald and Giemsa reagents. The 
area encompassed by each nucleus was quantified by microscopy using the Analyze 
Particles feature in FIJI (Schindelin et al., 2012). Results represent mean ± SD for 3 
independent experiments with >50 cells counted per treatment group per experiment. 
*p<0.05, **p<0.01. 
 
 
 
	  	  	  
83 
 
Figure 3.9. The Trim58 PRY-SPRY domain binds the molecular motor dynein. (A) 
Domain structures of Trim58 showing the “tripartite” RING-BBox-Coiled Coil (CC) motif 
and the immunoglobulin-like PRY-SPRY domain. Amino acid numbers are indicated. In 
some TRIM proteins, the RING domain recruits E2 conjugases carrying activated 
ubiquitin and the PRY-SPRY domain binds substrates. (B) FLAG-tagged Trim58 PRY-
SPRY domain (PS), or vector (V), were stably expressed in G1E proerythroblast cells. 
Lysates were immunoprecipitated (IP) with FLAG antibody, fractionated by SDS-
polyacrylamide gel electrophoresis, and stained with Coomassie Blue Silver. Numbered 
arrows denote the regions of the gel from which bands were excised for mass 
spectrometric (MS) analysis. Bands from both V and PS IPs were analyzed. MS 
identified peptides from dynein heavy chain (DHC), dynein intermediate chain (DIC), 
dynein light intermediate chains 1/2 (DLIC), and Trim58 PRY-SPRY (PS) predominantly 
in Bands 1, 3, 4, and 5, respectively. These proteins were only identified in bands from 
the PS IP lane. See Tables 3.1 and 3.2 for a full listing of identified proteins. Inp, input 
(1%). (C) Lysates of G1E cells expressing FLAG-PS or vector (V) were 
immunoprecipitated with FLAG antibody and analyzed by Western blotting 
(immunoblotting, IB) for DHC, DIC, FLAG and Codanin1 (Cdan1, negative control). Inp, 
input (5%). (D) Embryonic day 14.5 murine fetal liver erythroblasts were lysed, 
immunoprecipitated with anti-DIC antibody or IgG control and analyzed by Western 
blotting for the indicated proteins. α globin was included as a negative control. Inp, input 
(0.5%). 
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Figure 3.9 
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Figure 3.10. Trim58 binds directly to the DIC amino terminus. (A) Recombinant 
purified GST-Trim58 PS domain (GST-PS) or GST alone were incubated with purified 
bovine holodynein complex and glutathione-Sepharose beads. Bound proteins were 
analyzed by Western blotting. Equal percentages of total input (Inp), pull down (PD) and 
supernatant (SN) samples were loaded. (B) 293T cells were transfected with expression 
plasmids encoding hemagglutinin (HA) fused to the indicated DIC amino acids. After 24 
hrs, cells were lysed and incubated with GST-PS or GST and glutathione-Sepharose 
beads. Bound proteins were analyzed by anti-HA Western blotting. PD, pull down. SN, 
supernatant (1%). (C) SEC-MALLS data for PS, GST-DIC(1-120) and a 1:1 mixture. 
Protein concentration was measured on an inline refractive index detector. Light 
scattering data converted to molecular weight are shown above each chromatography 
trace and relate to the right-hand y-axis. The observed molecular weights are consistent 
with a 1:1 interaction between the two proteins augmented by the dimerization of the 
GST tag appended to DIC(1-120). (D) DIC domain structure showing the amino-terminal 
coiled coil (CC) motif, which binds Trim58. This region of DIC also binds 
dynactin/p150Glued and NudE, which are previously characterized regulators of dynein 
function (McKenney et al., 2011). The DIC carboxy-terminal domain contains WD 
repeats that interact with DHC. Amino acid numbers are indicated (aa#).  
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Figure 3.11. Trim58 facilitates dynein degradation. (A) Schematic diagram showing 
full length Trim58 constructs with amino-FLAG and carboxyl-mCherry tags. The RΔ 
mutant contains two missense mutations in the RING domain that abrogate ubiquitin 
ligase activity. (B) Western blot analysis of Trim58-expressing HeLa cells. Cells were 
infected with retrovirus encoding FLAG-Trim58 (WT or RΔ) or vector (V), selected in 
puromycin for 3 days, then analyzed by Western blotting before or after treatment with 
the proteasome inhibitor MG132 (10 µM) for 4 hrs at 37 ºC.  
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Figure 3.12. Trim58 expression causes Golgi spreading, a marker of dynein 
dysfunction. Assessment of Golgi structure in HeLa cells expressing Trim58. HeLa 
cells were transfected with expression plasmids encoding Trim58-mCherry or CC1-
mCherry, a dynein inhibitor (Quintyne et al., 1999). After 36 hrs, the cells were fixed, 
stained for the Golgi matrix protein GM130 and DNA (DAPI), and visualized by confocal 
microscopy. The percentage (%) of mCherry (mCh) positive cells that displayed normal 
punctate perinuclear Golgi body distribution is shown at right. The results represent 
mean ± SD for 3 independent experiments, with >100 cells counted per experiment. 
**p<0.01 vs. Vector control.  
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Figure 3.13. Trim58 expression perturbs mitotic progression. (A) Mitotic progression 
in HeLa cells expressing Trim58-mCherry constructs was analyzed by time-lapse 
microscopy. Representative images show mitotic progression in outlined cells. Cells 
expressing WT Trim58 exhibit delayed progression from cell rounding (~metaphase) to 
anaphase, compared to cells expressing vector or RΔ Trim58. BF, Brightfield; mCh, 
mCherry. Scale bar, 16µm. (B) Quantitative analysis of mitosis in Trim58-expressing 
HeLa cells. The graph on the left shows time elapsed between cell rounding and 
anaphase. The results represent mean ± SD for all observed mitotic cells. **p<0.01. The 
graph on the right shows the percentages of cells with delayed (>200 min) or failed 
mitosis manifested as cell death between rounding and anaphase. (V, n=134 normal 
mitoses; WT, n=50 normal, 13 delayed, 11 failed mitoses; RΔ, n=100 normal, 7 delayed 
mitoses).  
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Figure 3.14. Trim58 expression correlates with loss of dynein and enucleation 
during erythroid maturation. Fetal liver erythroblasts were infected with retrovirus 
encoding shRNA against (A) luciferase (shLuc) or (B) Trim58 (shRNA #4), cultured in 
expansion medium for 72 hrs, and shifted to maturation medium at time 0. Whole cell 
lysates were prepared at the indicated time points and analyzed by Western blotting. A 
control sample from 44 hrs maturation was run in the lane marked “+” as a positive 
control for Trim58. (C) Rate of enucleation in cells from panels A and B, determined as 
shown in Figure 3.4A. The results represent mean ± SD for 4 biological replicates. 
*p<0.05; **p<0.01; ns, not significant.  
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Figure 3.14. 
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Figure 3.15. Trim58 deficiency causes aberrant dynein protein retention in late 
stage erythroblasts. Erythroblast cultures expressing control constructs (Vector, shLuc) 
or Trim58-directed shRNAs (sh58 #4, sh58 #7) were expanded in puromycin for 72 hrs, 
then induced to mature for 48 hrs and collected for analysis. (A) Whole cell lysates were 
analyzed by Western blotting for the indicated proteins. DHC, dynein heavy chain; DIC, 
dynein intermediate chain. (B) Whole cell lysate cDNA was analyzed by semiquantatitive 
real time PCR for dynein intermediate chain (Dync1i2), dynein heavy chain (Dync1h1) 
and Trim58. The y-axis represents mRNA expression level compared to the average 
value for control-treated samples (Vector, shLuc), which was set at 1. Results represent 
mean ± SD for 4 biological replicates. **p<0.01; ns, not significant. 
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Figure 3.16. Overview of the parameters used to analyze erythroblasts by imaging 
flow cytometry. (A) Morphology parameters used to assess the steps of erythroblast 
enucleation during imaging flow cytometry. Nuclear condensation is reflected by reduced 
nuclear diameter (broken line). The aspect ratio (minor axis (blue line) divided by major 
axis (red line)) decreases as cells become oblong during nuclear extrusion. The Δ 
centroid (distance between centers of the nucleus (red) and cytoplasm (green)) 
increases during nuclear polarization and extrusion. (B) Representative analysis of fetal 
liver erythroblasts at 36 hrs maturation. Spherical nucleated erythroblasts are pink. 
Oblong cells extruding their nuclei (decreased aspect ratio and increased Δ centroid) are 
orange. Cells in late mitosis, visualized to the left of the orange gate, exhibit low aspect 
ratio and low Δ centroid. (C) Representative images of cells from panel B that are, 1) 
Spherical with a non-condensed centralized nucleus; 2) spherical with a condensed 
centralized nucleus; 3) spherical with a condensed polarized nucleus; and 4) oblong with 
a condensed extruding nucleus.  
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Figure 3.17. Trim58 functions between nuclear condensation and nuclear 
extrusion during erythroblast enucleation. Erythroblasts expressing GFP and control 
(shLuc) or Trim58 shRNA #4 were analyzed by imaging flow cytometry at the indicated 
times during maturation. The results represent mean ± SD for 4 biological replicates, 
~3000 cells analyzed per replicate. (A) Plot of the average nuclear diameter, 
demonstrating condensation over time. (B) Plot of the percent (%) spherical cells, 
including those that were centralized or polarized. (C) Plot of percent (%) oblong cells 
with extruding nuclei.  
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Figure 3.18. Trim58 regulates nuclear polarization during erythroblast enucleation.  
(A) Δ centroid distribution within spherical erythroblasts depicted in Figure 3.17B. Higher 
Δ centroid values indicate more polarized nuclei. Representative histograms are shown 
for three time points. Dashed white bars indicate the mean Δ centroid value for each 
plot. (B) Quantification of mean Δ centroid values in control (shLuc) or Trim58-deficient 
(shTrim58 #4) erythroblast maturation cultures. The results represent mean ± SD for 3 
biological replicates, ~3000 cells analyzed per replicate. *p<0.05, **p<0.01.  
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Figure 3.19. Trim58 and an intact microtubule network regulate nuclear 
polarization. (A) Erythroblast cultures were infected with retrovirus encoding Luciferase- 
(shLuc) or Trim58-directed shRNA (shTrim58 #4), expanded for 72 hrs in puromycin, 
then induced to mature for 26 hrs, fixed in paraformaldehyde and analyzed by imaging 
flow cytometry. In the bottom panel, shLuc-expressing cells were treated with 16 µM 
nocodazole at 37 °C from 22-26 hrs of maturation. Histograms show Δ centroid 
distribution within spherical erythroblasts from each treatment condition (see Figure 
3.16A). Higher Δ centroid values indicate more polarized nuclei. (B) Mean Δ centroid 
values for each treatment condition were calculated using the IDEAS software (Amnis) 
from the histograms in panel A.  
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Figure 3.20. Directional nuclear movement during erythroblast enucleation. 
Primary murine fetal liver erythroblasts were fixed, stained for microtubules (α tubulin, 
green) and DNA (DAPI, blue), and imaged by deconvolution fluorescent microscopy. 
Arrow indicates the microtubule organizing center (MTOC). Scale bar, 2 µm.  
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Figure 3.21. Model for the actions of Trim58 during erythroblast enucleation. In 
early maturation, the nucleus resides within a cage of microtubules (green) and dynein 
(blue) keeps the nucleus in close proximity to the MTOC (yellow). Induction of Trim58 
causes dynein degradation, which may promote nuclear polarization through multiple 
mechanisms. A microtubule motor imbalance may allow unopposed kinesin molecular 
motors to polarize the nucleus within a microtubule cage (top) and/or microtubule cage 
collapse could free the nucleus to polarize. Following polarization and microtubule 
disassembly, nuclear extrusion occurs. 
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Figure 3.22. Several kinesin family genes are expressed in late erythroblasts. 
Definitive murine orthochromatic erythroblasts were collected from (A) E14.5 fetal liver or 
(B) adult bone marrow and FACS-purified. Gene expression in these samples was 
analyzed by microarray (Kingsley et al., 2013). (C) Gene expression in primary human 
late (orthochromatic) erythroblasts, cultured from peripheral blood buffy coat 
mononucleocytes, was analyzed by microarray (Merryweather-Clarke et al., 2011). 
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Figure 3.23. Trim58 is expressed in megakaryocytes. (A) Trim58 mRNA levels were 
analyzed by RNA-Sequencing (RNA-Seq) in megakaryocyte-erythroid progenitor (MEP) 
cells, erythroblasts (Ery), and megakaryocytes (Mk) (data from Pimkin et al, in revision). 
The mRNA expression is quantitated as FPKM (fragments per kilobase of transcript per 
million reads). (B) Chromatin immunoprecipitation-sequencing (ChIP-Seq) analysis of 
transcription factor binding to the Trim58 locus in primary murine megakaryocytes (data 
from Pimkin et al, in revision). The blue line depicts the Trim58 gene, with exons shown 
as rectangles. Transcription factor binding sites are indicated in cyan. 
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CHAPTER 4:  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Summary statement  
Consistent with GWAS that linked TRIM58 SNPs with altered erythrocyte 
parameters (Kamatani et al., 2010; van der Harst et al., 2012) and gene expression 
studies that suggested Trim58 might be active during late erythroid maturation (Figures 
3.1 and 3.2), our investigation identified a role for this putative E3 ubiquitin ligase in 
erythroblast enucleation. Trim58 degrades dynein in temporal correlation with 
enucleation, whereas Trim58-deficient erythroblasts aberrantly retain dynein and fail to 
polarize, extrude, or expel their nuclei efficiently. Given the established role for dynein in 
regulating nuclear positioning (Fridolfsson and Starr, 2010; Splinter et al., 2010; 
Tanenbaum et al., 2011; Wilson and Holzbaur, 2012) and in preventing microtubule 
catastrophe at the cell periphery (Hendricks et al., 2012; Moore and Cooper, 2010), as 
well as studies implicating microtubule-based activities in nuclear polarization and 
extrusion during erythroblast enucleation (Figures 3.16-3.18 and (Konstantinidis et al., 
2012b; Wang et al., 2012)), we propose that Trim58-mediated dynein degradation is 
responsible for some aspects of nuclear movement during enucleation.  
Many questions are raised by our initial characterization of Trim58 biology, 
including: By what mechanism(s) does Trim58 promote enucleation? What is the role of 
Trim58 in vivo? How does Trim58 deficiency lead to multinuclearity? Does Trim58 
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function biochemically as an E3 ubiquitin ligase? How do TRIM58 SNP(s) alter its 
function? How do other GWAS-identified putative E3 ligases regulate erythropoiesis?  
Our findings identify a previously unappreciated role for regulated proteolysis in 
dynein regulation. It is possible that proteasomal degradation regulates dynein activity 
outside of the erythroid compartment, potentially making our findings broadly applicable 
for studies of dynein biology. Future studies will address the following questions: Does 
Trim58 regulate non-erythroid biology? Does regulated proteolysis influence dynein 
activities in non-erythroid cells?  
 
Ongoing and future studies 	  
By what mechanism(s) does Trim58 promote enucleation?  
Our model proposes that Trim58-mediated dynein degradation promotes 
enucleation by allowing unopposed kinesin(s) to polarize the nucleus and/or by 
depolymerizing microtubules to free the nucleus for extrusion (Figure 3.21). During 
erythroid maturation, dynein degradation must be exquisitely timed to promote 
enucleation without compromising dynein-dependent processes in earlier erythroblasts 
(Figure 3.14). This complicated our efforts to delineate the mechanism by which dynein 
promotes enucleation and also prevented us from analyzing whether dynein 
manipulations rescued enucleation in Trim58-deficient cells. Retroviral introduction of 
dynein-directed shRNAs or ectopic CC1 expression in cultured erythroblasts caused 
toxicity in early erythroblasts that precluded reliable analysis.  
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Rescue of Trim58-deficiency phenotypes will therefore likely require temporal 
treatment with a small molecule. Treatment with the cell permeable dynein motility 
inhibitor Ciliobrevin (Firestone et al., 2012) did not rescue enucleation in Trim58-deficient 
cultures (data not shown), suggesting that tonic motility-independent dynein forces may 
retain a condensed nucleus in the center of the cell. This is consistent with models in 
which dynein exerts tonic force on neuronal nuclei through a microtubule cage-like 
structure (Shu et al., 2004; Tsai et al., 2007; Xie et al., 2003). A similar microtubule 
structure exists in early erythroblasts (Figure 3.20). 
However, temporal dynein inhibition in late stage erythroblasts with CC1 protein 
should theoretically disengage aberrantly retained dynein from the nucleus in Trim58-
deficient cells. This may promote enucleation. We are therefore working to purify 
recombinant CC1 protein that contains a cell-permeable TAT tag (Wadia and Dowdy, 
2002, 2005). This TAT tag allows proteins to enter cells, including erythroblasts 
(Keerthivasan et al., 2012), via an endocytic process called macropinocytosis (Wadia 
and Dowdy, 2002, 2005). If successful, the addition of cell permeable CC1 to erythroid 
cultures could boost enucleation in our studies of Trim58-deficient erythroblasts. It also 
might augment enucleation in untreated murine erythroblasts. Furthermore, this reagent 
might promote enucleation in cultured human erythroblasts, which would aid 
investigations aimed to generate human erythrocytes for transfusion medicine 
(Migliaccio et al., 2012). Recombinant cell-permeable CC1 protein might also provide an 
easier alternative to microinjecting CC1 protein, which is a commonly used technique to 
temporally inhibit dynein activity in large adherent cells (i.e., U2OS or HeLa cells).  
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To discern whether nuclear polarization and enucleation depend on motor-based 
nuclear transport and/or microtubule cage collapse (Figure 3.21), we have investigated 
the effects of kinesin knockdown on enucleation. We hypothesized that Trim58-mediated 
dynein degradation would allow unopposed kinesin(s) to facilitate nuclear polarization. 
Although kinesin-1 regulates nuclear movement in multiple organisms and cell types 
(Fridolfsson and Starr, 2010; Splinter et al., 2010; Wilson and Holzbaur, 2012), our 
studies did not reveal a role for Kif5b in murine erythroid enucleation. This supports our 
microtubule cage collapse mechanism for enucleation (Figure 3.21). Alternatively, this 
could be due to compensation from other kinesin-1 isoforms, or other kinesins that are 
expressed in late erythroblasts might directly promote nuclear migration (Figures 3.22A 
and 3.22B).  
Other kinesins that are expressed in late erythroblasts might regulate enucleation 
in different ways (Figures 3.22A and 3.22B). Kif2a mRNA is abundant in murine 
orthochromatic erythroblasts, suggesting that this gene might regulate murine 
enucleation. Kif2a depolymerizes microtubules (Uehara et al., 2013), and microtubule 
depolymerization seems to be necessary for nuclear polarization and/or expulsion 
(Figures 3.20 and 3.21). Kif2a might therefore contribute to the microtubule cage 
collapse mechanism (Figure 3.21), which is otherwise difficult to investigate 
experimentally due to its highly temporal nature and the fragility of late erythroblasts in 
suspension culture. Kif20a and Kif23 are highly expressed in late stage murine 
erythroblasts (Figures 3.22A and 3.22B). These proteins localize to the central spindle 
during mitosis and regulate cell division (Hummer and Mayer, 2009; Uehara et al., 
2013). Targeted knockdown of Kif2a, Kif20a, or Kif23 in erythroblast cultures will 
determine whether these genes regulate enucleation and/or other aspects of late 
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erythroblast development. Protein interaction studies will investigate whether these 
kinesins have erythroid-specific isoforms or binding partners.  
Interestingly, the kinesins expressed in mouse and human orthochromatic 
erythroblasts differ (Figure 3.22). This is consistent with previous observations that many 
erythroid-specific RNAs are expressed differently in these two species (Paralkar et al., 
2014). Whereas Kif5b does not stand out as being highly expressed in murine 
orthochromatic erythroblasts (Figures 3.22A and 3.22B), KIF5B is clearly enriched 
among kinesin genes in late stage human erythroblasts (Figure 3.22C). Thus, KIF5B 
knockdown might inhibit nuclear polarization during enucleation of cultured human 
CD34+ cells, despite our negative results in murine erythroblast cultures.  
In addition to our proposed mechanisms (Figure 3.21), Trim58-mediated dynein 
proteolysis could promote enucleation via alternative, less well-characterized 
mechanisms. For example, Trim58-mediated dynein degradation may promote 
enucleation by inhibiting the dynein light chain Tctex-1, which binds and inactivates the 
RhoA guanine exchange factor GEF-H1 through holodynein-dependent microtubule 
recruitment (Meiri et al., 2012). Upon microtubule disassembly, Tctex-1 releases GEF-
H1, which in turn promotes GTPase-mediated actin stress fiber formation and 
actomyosin contractility.  Work presented in abstract form suggests that RhoA promotes 
erythroblast enucleation by stimulating contraction of the actomyosin ring (Konstantinidis 
et al., 2012a). Thus, Trim58-mediated dynein elimination may facilitate nuclear extrusion 
by de-repressing GEF-H1, which in turn activates RhoA, a positive regulator of the 
contractile ring. Pull down assays will examine whether activation of RhoA or its 
downstream effectors temporally correlates with enucleation and/or Trim58 activity.  
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Trim58-mediated dynein degradation might also regulate enucleation 
independent of nuclear movement. For example, lipid raft-containing vesicles are 
transported in a polarized fashion to the nucleus-reticulocyte boundary to facilitate 
enucleation (Keerthivasan et al., 2010). Mitochondria are also transported to the 
nucleus-reticulocyte boundary, although the reason for this is unclear (Simpson and 
Kling, 1967). The directional movement of these cargoes away from the MTOC is 
consistent with kinesin-mediated transport. Hence, dynein degradation might facilitate 
transport by allowing unopposed kinesins to perform this function. Morphologic and 
immunofluorescence assays will assess whether these cargoes are properly localized in 
control and late stage Trim58-deficient erythroblasts during enucleation.   
Trim58 could also facilitate erythroblast enucleation through interactions with 
other proteins that we identified in our screen, such as Nup153, Nup50, importin α, and 
importin β (Table 3.2). Nup153 provides a scaffold that recruits Nup50, importin α, and 
other factors to the nuclear pore (Makise et al., 2012). Nup153 also regulates mitotic 
progression (Mackay et al., 2009), which is particularly interesting in light of the fact that 
enucleation shares many processes with cell division (Keerthivasan et al., 2011; 
Konstantinidis et al., 2012b). Several studies have shown that dynein is localized to 
nuclear pores under certain conditions (Bolhy et al., 2011; Hu et al., 2013; Splinter et al., 
2010). Nuclear pore complex proteins may recruit Trim58 to the nuclear envelope in 
order to enhance dynein degradation at this location, which would be particularly 
important for release of the nucleus during enucleation. Immunofluorescence studies will 
investigate whether Trim58, NPC proteins, and dynein colocalize at the nuclear 
envelope during enucleation. However, these studies will first require the generation of a 
reliable antibody to detect endogenous Trim58 by immunofluorescence assay.   
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Furthermore, it is possible that Trim58 promotes enucleation through interactions 
with as-yet-unidentified proteins. RING (Brzovic et al., 2001), BBox (Schweiger and 
Schneider, 2003; Trockenbacher et al., 2001), and Coiled Coil (CC) (Endo et al., 2012) 
domains from Trim proteins and other E3 ligases (i.e., BRCA1 and BARD1 (Brzovic et 
al., 2001)) mediate protein interactions. Proteins that interact with the BBox or CC 
domains of some Trim proteins are degradation substrates (Endo et al., 2012; 
Trockenbacher et al., 2001). Immunoprecipitation-mass spectrometry studies utilizing full 
length Trim58 may identify novel protein interactors. Quantitative approaches (for 
example, stable isotope labeling by amino acids in cell culture (SILAC) (Geiger et al., 
2011)) could also be used to identify Trim58 degradation substrates in HeLa cells 
ectopically expressing Trim58, or in Trim58-deficient late erythroblasts, compared to 
controls.  
 
What is the role of Trim58 in vivo? 
We have recently generated a mouse lacking Trim58 exon 3, which contains the 
coiled coil region of the Trim58 protein (Trim58CC-/CC-). The coiled coil domain is critical 
for the functions of other Trim proteins (Javanbakht et al., 2006; Reymond, 2001; Streich 
et al., 2013). Initial erythroid phenotypic analyses in mixed-background knockouts were 
conducted with Elizabeth Traxler (U. Pennsylvania Perelman School of Medicine 
Medical Scientist Training Program and Children’s Hospital of Philadelphia). These 
revealed a mild reduction in reticulocyte counts in juvenile mice (~5 weeks old) that 
resolved by ~16 weeks of age. Recovery from phenylhydrazine-induced hemolytic stress 
was normal in 12-16 week-old mice. We have not observed defective enucleation in 
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cultured Trim58CC-/CC- murine erythroblasts, and are currently investigating whether 
dynein degradation is delayed during maturation of Trim58CC-/CC- erythroblasts.  
There are two potential reasons for our negative findings in adult mice. First, it is 
possible that hypomorphic Trim58CC-/CC- protein is expressed, and that this protein 
retains some ability to interact and degrade dynein. Indeed, messenger RNA encoding 
Trim58CC-/CC- is expressed in late erythroblasts, although protein levels were reduced by 
western blot analysis (data not shown). We will assess whether Trim58CC-/CC- protein 
binds recombinant purified GST-DIC(1-120) through in vitro pull down assays. Ectopic 
expression of Trim58CC-/CC- in HeLa cells will examine whether the truncated protein can 
promote dynein degradation. If this protein retains activity, this would be important 
knowledge for the field as it would go against the prevailing dogma for how Trim proteins 
function. In this case, we will also consider new strategies to generate true Trim58 
knockout mice.  
Alternatively, Trim58CC-/CC- mice may indeed be “true knockouts” if this protein is 
unstable and/or dysfunctional. Compensatory processes in Trim58CC-/CC- cells might 
therefore be expected to facilitate efficient enucleation of knockout fetal liver 
erythroblasts. Microarray analysis of late stage murine fetal liver erythroblasts from WT 
and Trim58CC-/CC- mice might reveal the identities of compensatory genes. Protein 
interaction and/or proteomic studies in control and Trim58CC-/CC- erythroblasts might also 
reveal whether other E3 ubiquitin ligases can target dynein for degradation in the 
absence of Trim58.  
Trim58CC-/CC- or other Trim58-knockout mice will help us investigate whether 
Trim58 influences erythropoiesis outside of its role in enucleation. Most Trim proteins are 
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thought to regulate innate immunity (Napolitano and Meroni, 2012; Versteeg et al., 
2013), commonly by suppressing immune response pathways (see for example (Booth 
et al., 1998)). Trim58 expression in late erythroblasts may negatively modulate immune 
signaling. Indeed, nucleated avian and fish erythrocytes play incompletely understood 
roles in immune response regulation (Morera et al., 2011; Passantino et al., 2007), and 
late stage nucleated murine erythroblasts were recently shown to have immune-
regulatory functions in neonatal mice (Elahi et al., 2013). Given these findings, 
enucleation could be viewed as a Trim58-mediated immunosuppressive event, since 
anucleate erythrocytes cannot respond transcriptionally to cytokine signals. Alternatively, 
Trim58 might regulate immune functions in late stage nucleated erythroblasts. Co-
culture of neonatal control or Trim58-deficient late stage erythroblasts with adult immune 
cells (Elahi et al., 2013) will test whether Trim58 is important for erythroblast-mediated 
cytokine production and other immune cell responses to bacterial infection.  
 
How does Trim58 deficiency lead to multinuclearity?  
Several diseases that affect erythroid development yield multinucleated 
erythroblasts in the bone marrow, including CDA (Renella and Wood, 2009) and 
myelodysplastic syndrome (Yoshida, 1996). KIF23, which regulates mitotic progression 
in many cell types, is the causative gene for CDA type III (Liljeholm et al., 2013b). This 
finding suggests that defective cell division during terminal erythropoiesis yields 
multinucleated erythroblasts and underlies at least some aspects of disease pathology 
(Traxler and Weiss, 2013). 
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We noted increased multinuclearity in mature Trim58-knockdown erythroblasts 
(Figure 3.5). Thus, in addition to its role in enucleation, Trim58 might regulate the 
“normal” cell division(s) during terminal erythropoiesis. Many proteins regulate 
cytokinesis (Eggert et al., 2006), including Trim58-interactors dynein (Moore and 
Cooper, 2010) and Nup153 (Mackay et al., 2009). Histologic analysis of bone marrow 
from Trim58CC-/CC- mice did not demonstrate multinucleate erythroblasts, but as 
discussed previously this could be the result of retained Trim58CC-/CC- protein activity. 
Future studies will be aimed at identifying what steps of mitosis, if any, are deregulated 
in the absence of Trim58 through immunofluorescence and/or time lapse microscopy of 
developing Trim58-knockdown or Trim58-knockout erythroblasts.  
 
Does Trim58 function biochemically as an E3 ubiquitin ligase? 
Ectopic Trim58 expression in HeLa cells causes proteasome-mediated dynein 
degradation (Figure 3.11). There are multiple mechanisms by which this could occur. 
Trim58 could facilitate transfer of ubiquitin directly onto bound DIC and/or other dynein 
subunits. This is the canonical mechanism of action for E3 ubiquitin ligases (Komander, 
2009). Alternatively, the interaction between Trim58 and DIC could stimulate Trim58 
autoubiquitylation and subsequent translocation of Trim58, DIC, and any other bound 
proteins to the proteasome for degradation. This is the mechanism by which Trim21 
degrades IgG-bound viral particles (Mallery et al., 2010). Denaturing 
immunoprecipitation experiments using HeLa cells ectopically expressing WT or RING-
dead Trim58 protein are currently in progress to answer this question.  
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The nature of the polyubiquitin chains catalyzed by Trim58 activity will also be 
interesting to investigate. Polyubiquitin chains formed through linkage at lysine 48 (K48) 
are typically thought to target substrates for degradation by the 26S proteasome 
(Komander, 2009). However, several other lysine linkage options exist. These 
possibilities will be addressed through in vitro ubiquitylation experiments utilizing 
recombinant WT or RING-dead Trim58, purified holodynein and/or DIC truncations as 
substrates, and commercially available UPS reagents including E1 and E2 enzymes, 
and ubiquitin variants that contain single lysine mutations (i.e., K48A or K63A). 
Moreover, some Trim proteins promote transfer of ubiquitin-like moieties, such as SUMO 
(Chu and Yang, 2011) or ISG15 (Napolitano and Meroni, 2012), onto substrates. We will 
assess whether Trim58 mediates such activity through in vitro and cell-based assays 
and, if so, to determine the identities of its targets. 
 
How do TRIM58 SNP(s) alter its function? 
TRIM58 single nucleotide polymorphisms (SNPs) have been linked with 
microcytosis (small erythrocytes) and higher erythrocyte count (van der Harst et al., 
2012). It will be interesting and important to identify the causative polymorphism(s). 
There are no common polymorphisms in gene regulatory regions within linkage 
disequilibrium of the identified TRIM58 SNPs (analyzed with the help of Dr. Daniel 
Bauer, Children’s Hospital Boston). However, SNPs within TRIM58 exons are predicted 
to cause missense mutations in the resulting protein. For example, the polymorphism 
rs3811444, which occurs in 20-25% of all chromosomes, causes a T394M mutation in a 
variable loop within the TRIM58 PRY-SPRY domain. A potentially disruptive missense 
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mutation at the analogous position in a TRIM20/Pyrin PRY-SPRY loop causes Familial 
Mediterranean Fever (Booth et al., 1998), although the functions of this mutant protein 
have not been specifically investigated. Protein interaction studies using a TRIM58 PRY-
SPRY domain that contains this missense mutation may reveal defects in its association 
with DIC or other known interactors (see Tables 3.1 and 3.2).  
 
How do other GWAS-identified E3 ligases regulate erythropoiesis? 
GWAS have also linked SNPs associated with several other putative and 
validated E3 ligases with altered erythrocyte parameters (Kamatani et al., 2010; Nuinoon 
et al., 2009; Soranzo et al., 2009; van der Harst et al., 2012). The work in this thesis 
demonstrates that functional follow-up studies on GWAS hits can elucidate novel and 
interesting biology (see for example (Sankaran et al., 2012)). Studies of other E3 ligases 
implicated in regulating erythrocyte parameters might elucidate new and exciting aspects 
of erythroid biology.  
 
Does Trim58 regulate non-erythroid biology? 
A TRIM58 SNP has been associated with altered platelet count (Gieger et al., 
2011), implicating TRIM58 in megakaryocyte development and/or platelet formation. 
Megakaryocyte development involves endomitosis, which entails DNA replication without 
cell division, and later the elaboration of long tubular cytoplasmic protrusions called 
proplatelets (Italiano et al., 2007). Proplatelets ultimately separate from the 
megakaryocyte and undergo further maturation into platelets. The cellular and molecular 
basis for proplatelet formation is not well understood (Italiano et al., 2007).  
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Proplatelets use bipolar microtubule arrays to elongate from differentiated 
megakaryocytes (Patel et al., 2005). Rather than strict addition of tubulin subunits to 
growing microtubules, this occurs in part via dynein-dependent sliding of antiparallel 
microtubules (Patel et al., 2005). Trim58-mediated effects on dynein might regulate this 
process. Given that dynein has been implicated in microtubule sliding dynamics during 
proplatelet production, Trim58-mediated dynein degradation might inhibit sliding to signal 
completion of proplatelet elongation and/or instigate proplatelet separation from 
megakaryocyte.  
Trim58 could also influence platelet maturation from proplatelets. While 
proteomic studies indicate that both dynein and TRIM58 protein are retained in mature 
platelets (Burkhart et al., 2012), immunofluorescence images demonstrate that the levels 
of dynein are substantially lower in platelets versus proplatelets (Patel et al., 2005). 
Platelets contain 0.8 µg dynein per gram of tissue (Rothwell and Calvert, 1997). This is 
~30% of the dynein levels found in neurons (Paschal and Vallee, 1987; Schnapp and 
Reese, 1989). This could indicate that TRIM58 degrades some, but not all dynein in 
proplatelets. Consistent with this hypothesis, Trim58 mRNA is induced ~3.6-fold versus 
megakaryocyte-erythroid precursors during megakaryopoiesis (Figure 3.23). This is 
decreased compared with the 11.4-fold induction seen during erythropoiesis, which is 
associated with complete dynein loss.  
TRIM58 might also regulate aspects of platelet function. Platelet activation 
causes dynein redistribution from soluble cytoplasmic granules to an insoluble, perhaps 
microtubule-associated fraction by immunofluorescence and sedimentation assays 
(Rothwell and Calvert, 1997). Murine fetal liver megakaryocyte cultures treated with 
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control or Trim58-directed shRNAs will be used to assess proplatelet elongation, platelet 
formation, and/or platelet function by time-lapse microscopy, immunofluorescence, and 
Immunoprecipitation assays.  
It is also possible that transient or low-level Trim58 expression regulates 
biological processes outside of hematopoiesis. For example, in keeping with an 
immunomodulatory role for Trim proteins (Napolitano and Meroni, 2012; Versteeg et al., 
2013), it is possible that Trim58 is upregulated in response to viral infection and/or 
interferon signaling. In fact, ectopically expressed Trim58 enhanced nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB) and interferon β (IFNβ) signaling 
in HEK293T cells, and Trim58 knockdown interfered with the latter upon viral infection 
(Versteeg et al., 2013). Interestingly, dynein mediates retroviral integration (Bremner et 
al., 2009), and microtubule depolymerization, dynein, and dynactin can regulate NF-κB 
signaling (Rosette and Karin, 1995; Shrum et al., 2009). It is possible that acute Trim58 
induction may transiently degrade dynein to prevent retroviral integration without 
adversely affecting cell viability. Furthermore, Trim58 might competitively inhibit viral 
association with dynein, since Trim58 and adenoviral hexon both interact with a similar 
region on DIC (Bremner et al., 2009). HeLa cells infected with virus and/or treated with 
interferon will be used to assess endogenous Trim58 induction under these conditions. If 
this proves true, it would provide a more rapid and facile system in which to study 
endogenous Trim58 functions compared to our current fetal liver erythroblast culture 
model. Further studies would examine Trim58-mediated dynein ubiquitylation and/or 
proteolysis in response to viral infection, and also biochemically investigate whether 
Trim58 competitively inhibits viral binding to DIC using purified proteins.  
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Does regulated proteolysis influence dynein activities in non-erythroid cells? 
Although this thesis has focused primarily on the role of Trim58, our studies have 
uncovered new and interesting aspects of dynein biology. With the exception of late 
stage erythroid cells, dynein is expressed in all mammalian cell types. This makes our 
findings potentially relevant for many aspects of cell biology, since dynein proteolysis 
would be expected to potently regulate cell division, intracellular transport, and cell 
migration. Notably, Trim58 need not be expressed in these cells, as alternative dynein-
specific E3 ligases might exist. In fact, other Trim proteins might function in this way. 
Trim5α colocalizes with dynein by immunofluorescence (Diaz-Griffero et al., 2006) and 
Trim50 promotes PI3K-dependent gastric vesicle secretion (a plus end-directed process, 
directionally consistent with nuclear movement during erythroid enucleation) (Nishi et al., 
2012). An initial screen for dynein ubiquitylation in several different tissue types may 
reveal the generality of this mechanism, and protein interaction studies may reveal other 
E3 ligases that facilitate dynein ubiquitylation. The results could impact our 
understanding of tissue development, neurodegenerative diseases, oncogenesis and 
metastasis.	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